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Abstract 
Nanoparticles are increasingly important in biotechnology as they are extensively used as drug 
delivery carriers and in biosensors. In both these two contexts, protein-nanoparticle interactions 
are often involved. Proteins that are present in body fluids inevitably interact with nanoparticle 
based drug carriers and typically surround them forming the so called “protein corona”. 
Biosensors that are based on nanoparticles often have proteins deliberately attached to their 
surface, for example antibodies that bind specific analytes. The understanding of the assembly 
mechanisms at the protein-nanoparticle interface and the ability to engineer proteins that 
interact with nanoparticles in the desired way, are therefore two essential requisites for the 
future development of nano-medicines and nano-biosensors.   
In this work, we focused on the interaction of proteins with gold nanoparticles (GNPs). GNPs 
are available with a broad range of surface chemistries, suitable for the conjugation of many 
biomolecules. Although there are at least three decades of studies on gold colloids with 
different surface chemistries, there is still quite little known about what are the exact features 
of a protein that determine its adsorption onto gold. We developed methods to study this and 
applied them to characterise the adsorption on GNPs of Glutathione-S-Transerase (GST), 
which was reported previously as a protein that strongly binds gold. We determined its affinity 
and kinetics of binding and unravelled the mechanism of its thiol-mediated chemisorption. We 
found that GST binds to GNPs even more efficiently than other known gold-binding proteins, 
such as Bovine Serum Albumin (BSA). We concluded that GST could be considered a very 
useful gold-protein interface, especially considering that GST fusion is routinely used for 
affinity purification of recombinant proteins and therefore well established.  
We also fused self-assembling proteins to GST or chemically cross-linked them to BSA.  The 
scope was to explore the feasibility of hierarchical and ordered assembly of designer proteins 
onto GNPs, with the ultimate goal of providing a convenient tool for modular assembly of 
proteins onto nanomaterials. It is known that proteins tend to denature and lose their function 
when in contact with GNPs, which is not optimal for biosensors or in nanomedicine. We found 
that it is possible to use GST or BSA to form a sacrificial layer on gold, which exposes linked, 
self-assembling proteins that are able to bind their counterpart, unaffected by the GNP surface. 
We reported two proof-of-concepts: the first based on mimics of the self-assembling neuronal 
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SNARE proteins and the second based on the pair SpyCatcher/SpyTag, derived from 
Streptococcus pyogenes proteins and used in bio-conjugation for their ability to self-catalyse 
the formation of isopeptidic bonds. 
We believe that the novel methods and original results presented in this thesis apply to both the 
understanding and the engineering of the protein-nanoparticle interface and will be beneficial 
for the broad nanobiotechnology community. In fact, our findings have potential applications 
in a broad range of fields, spanning from the improvement of the circulation life-time of 
nanomedicines by preventing the binding of serum protein and opsonisation, to the 
improvement of the manufacturing of GNPs-based immune-biosensors such as those used in 
lateral flow devices. 
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Chapter 1. Introduction 
 
1.1 Gold Nanoparticles 
 
Gold nanoparticles (GNPs) are widely used and have a long history in biology, chemistry and 
medicine. The earliest popular application of GNPs was the use for staining glass in Roman 
times, based on their optical properties. The first modern synthesis of GNPs could be dated 
back to 150 years ago by the work of Michael Faraday(Hayat 2012). What follows was a high-
yielding synthesis method of GNPs by Turkevich(Turkevich, Stevenson et al. 1951) which is 
still used often nowadays.  
In my project, I focus on interaction between protein and GNPs to understand the adsorption 
mechanism and develop new systems to assemble gold nanoparticles through proteins. 
In this section, the synthesis of gold nanoparticles, the functionalization of GNPs and the 
applications of functionalized GNPs are introduced. 
1.1.1 Chemical Synthesis of Gold Nanomaterials 
 
Gold nanoparticles (or gold nanospheres, gold colloids) of diameter from 1nm to 150nm can 
be synthesized by varying the ratios of gold salt (HAuCl4) and reducing agents. The different 
synthesis methods result in various capping agents (Table1.1) (Ghosh, Han et al. 2008). 
Different capping agent of GNPs are used for decoration with different biological molecules.  
Citrate-functionalized gold nanoparticle are most often synthesised using the method based on 
the work of Turkevich(Turkevich, Stevenson et al. 1951) and Frens (Frens 1973). Basically, 
the larger amount of sodium citrate yield smaller gold nanoparticles. The homogeneously 
distributed GNPs display a narrow and single absorption peak in the visible range between 
505nm and 560nm. The absorption peak of GNP shifts to a longer wavelength with an 
increasing size.  
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Core size (d) Synthetic methods capping agents 
1-2 nm Reduction of AuCl(PPh3) with diborane or sodium borohydride Phosphine 
1.5-5 nm Biphasic reduction of HAuCl4 by sodium borohydride in the presence 
of thiol capping agents 
Alkanethiol 
10-150 nm Reduction of HAuCl4 with sodium citrate in water Citrate 
Table 1.1 Table Summary of synthetic methods and capping agents of GNPs(Ghosh, Han et al. 2008) 
In recent studies, there are plenty of gold nanomaterials with non-spherical shape such as 
nanorods. Gold nanorods can be used in a variety of applications, for example in biosensors(Yu 
and Irudayaraj 2007), imaging (Huang, El-Sayed et al. 2006) and self-assembly(Thomas, 
Barazzouk et al. 2004). Compared to the single absorption peak of nanoparticles, gold nanorods 
display two peaks(Gole and Murphy 2004) including short-axis (transverse) and long-axis 
(longitudinal). Typically, the peak of transverse axis is in the visible range, whereas the peak 
of longitudinal axis can be either in the visible or in the near-infrared (NIR) range, depending 
on the dimensions of the nanorods.  
The research in this thesis is based on gold nanospheres only, however the principles could be 
applied to nanorods too.  
1.1.2 Functionalization of Gold Nanoparticles 
 
Gold nanoparticles have been widely used in biomedical applications for decades, mainly for 
their wide size range and biocompatibility. The surface area-to-volume ratio of spherical 
nanoparticles is high, which provides a high density loading of biological molecules.  2nm 
GNPs can covalently bind approximately 100 small ligands(Hostetler, Wingate et al. 1998). 
This provides a high potential for GNPs functionalization with amines and amino acids, 
peptides, proteins and oligonucleotides (Table 1.2).  
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Biological Molecule Applications References 
Amines and amino acid 
Gene delivery (Lee, Bae et al. 2008) 
Intracellular targeting (Ghosh, Kim et al. 2008) 
Nucleic acid 
Nucleic acid detection (Seferos, Giljohann et al. 2007) 
Signal amplification (Niazov, Pavlov et al. 2004) 
Peptide 
Small molecule detection (Sener, Uzun et al. 2013) 
Antisense gene regulation (Patel, Giljohann et al. 2008) 
Protein 
Labeling and imaging 
(Felsenfeld, Choquet et al. 1996) 
(Sokolov, Follen et al. 2003) 
(Albrecht-Buehler 1977) 
Cancer therapy (Cai, Gao et al. 2008) 
Drug delivery 
(Weerapreeyakul, Hollenbeck et al. 2000) 
(Bernkop-Schnürch, Guggi et al. 2004) 
Table 1.2  Biological applications of gold nanoparticles 
In order to improve the stability of naked GNPs solutions and prevent aggregation, amines and 
some small amino acid molecules have been added during the synthesis. Aslam(Aslam, Fu et 
al. 2004) demonstrated a novel one-step method to synthesis amine-capped gold nanoparticles 
by using oleyl amine as the reducing/stabilizing agent. The oleyl is added into heated gold 
colloidal solution with chloroauric acid, resulting in a maximum shift of the surface plasmon 
band from 520nm to 571nm. Studies by Japanese scientists(Niidome, Nakashima et al. 2004) 
found that amine-modified GNPs could form complexes with DNA plasmids and the GNPs-
plasmid conjugates transfect to HeLa cells and increase the gene expression about 100 fold 
(Figure 1.1). The amines-capped gold nanoparticles are positively charged which could form 
polyelectrolyte complexes through electrostatic interactions with negatively charged small 
interfering Ribonucleic Acid (siRNA)-polyethylene glycol (PEG) conjugates(Lee, Bae et al. 
2008). This research shows that the PEG-conjugated siRNA coated amine-GNPs are more 
internalized by human prostate carcinoma PC-3 cells than PEG-siRNA alone.  
 
Figure 1.1 GNPs-plasmid conjugates transfected to cell(Niidome, Nakashima et al. 2004). 
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Covalent conjugation to gold nanoparticles can be based on gold-thiol bond (Au-S). Brust 
reported a thiol monolayer coated gold nanoparticles in water-toluene system. AuCl4ˉ reduced 
sodium borohydride in the presence of alkanethiol, and resulted in 1-3nm gold nanoparticles 
with thiol coating(Brust, Walker et al. 1994). However, alkanes cannot be used to bind 
biological molecules. Based on this work, Majzik synthesized gold nanoparticles with 
cysteines. The thiol was attached to the gold surface, and carboxylate groups (-COOˉ) and 
amino groups (-NH3+) were available for further binding (Majzik, Fülöp et al. 2010).  Gold 
nanoparticles could be coated with carboxylate groups by using glutamic acid as the reducing 
agent. Wangoo conjugated the amino groups of BSA and anti-BSA antibody to carboxylate 
coated GNPs through electrostatic attraction (Figure 1.2). Circular dichroism results shown 
that BSA and anti-BSA undergoes a more flexible conformational state on the surface of gold 
nanoparticles. The substantial conformational transition from α-helix to β-sheet structure was 
observed after proteins conjugation to GNPs(Wangoo, Bhasin et al. 2008).  
 
Figure 1.2 Amino acid functionalized GNPs. The schematic representation of glutamic acid reduced gold nanoparticles 
capped with the amino acid and their subsequent binding with protein through the surface lysine residues of protein 
molecules(Wangoo, Bhasin et al. 2008). 
Nucleic acid has been used effectively for functionalizing gold nanoparticles for many 
applications. Mirkin’s group leads the research on attaching and controlling the amount of 
nucleic acid to different sizes of GNPs through thiol-gold bonds. The maximum loading of 
DNA coverage on GNPs was obtained by salt aging the nanoparticles to ~0.7M NaCl in the 
presence of DNA containing a poly-(ethylene glycol) spacer, and the 250nm GNPs have ~2 
orders of magnitude higher DNA loading than smaller (13-30nm) GNPs(Hurst, Lytton-Jean et 
al. 2006). Chen et al. studied the kinetics and thermodynamics of DNA hybridization on gold 
nanoparticles and they found that, at low surface densities, ssDNA adsorbs onto the GNP first, 
and then diffuses on the surface until hybridizing with an immobilized DNA(Chen, Wang et al. 
2009). The secondary structure of a DNA hairpin inhibits the interaction between DNPs and 
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DNA, therefore, the stability of the DNA hairpin adhered to GNPs was increased. The DNA 
functionalized GNPs were employed for transfection and mRNA detection in living 
cells(Seferos, Giljohann et al. 2007). GNPs functionalized with a recognition sequence were 
complemented with a Cy5 labelled reporter strand which was able to be displaced by target 
RNA (Figure 1.3). 
 
Figure 1.3 DNA capped GNPs. Functionalized GNPs for transfection and mRNA detection in living cells(Seferos, 
Giljohann et al. 2007). 
Peptides are commonly used molecules for functionalizing gold nanoparticles. Peptides 
normally contain positively charged amino acids such as lysine and arginine(Goldfarb, Gariépy 
et al. 1986) which provide an environment to combine with negatively charged GNPs. It is also 
known that tyrosine could be used to reduce HAuCl4(Slocik, Naik et al. 2005), Slocik 
demonstrated a simple one-pot process for synthesizing gold nanoparticles by using A3 peptide 
which containing tyrosine(Slocik, Stone et al. 2005). However, the A3 peptide lost the affinity 
property to recognize biological molecules. CALNN (Figure 1.4) is a peptide which can 
remarkably stabilized gold nanoparticles. In order to understand how the sequence of peptides 
affects GNPs stability, Fernig’s group designed 49 peptides based on CALNN, and the 
variation criteria were peptides length, the anchor (first amino acid), the peptide core (second 
and third amino acids), and the peptides carboxyl terminus (fourth and fifth amino acids).The 
experiment also included 9 sequences with no direct relation to CALNN for comparison(Lévy, 
Thanh et al. 2004). It was shown that the stability of peptide-capped GNPs depends on their 
length, hydrophobicity and charge. The sequences containing 5 amino acids gave the highest 
stability to gold nanoparticles. The presence of a thiol and cohesive lateral interactions between 
the peptides through hydrophobic or hydrogen bonds increased the GNPs solution stability.  
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Figure 1.4 The CALNN structure(Slocik, Stone et al. 2005). 
Moreover, an arginine-rich peptide (CALNNR8 (R is arginine)) has been derived from CALNN, 
and has been developed as a cell-targeting agent. Peptides mixture  (90% CALNN and 10% 
CALNNR8) were used to functionalize gold nanoparticles (30nm) for intracellular component 
targeting(Sun, Liu et al. 2008)  because of high affinity of endoplasmic reticulum to arginine. 
These peptide-GNPs conjugates are now used to translocate GNPs to cells for cancer treatment. 
Anil and his colleagues modified 2nm GNPs with the therapeutic peptide (PMI(p12)) and a 
targeted peptide (CRGDK) for selective binding to neuropilin-1(Nrp-1) receptors which 
overexpressed on the cancer cell surfaces(Kumar, Ma et al. 2012). CRGDK-GNPs conjugates 
increase the binding between CRGDK peptide and targeted Nrp-1 receptor overexpressed on 
cancer cell surface, finally improving the delivery of the therapeutic P12 peptide inside targeted 
cells (Figure 1.5). This could be a promising anti-cancer system to get a good efficacy for 
therapeutic molecules.  
 
Figure 1.5 Peptide capped GNPs. Interaction between the receptor and targeted ligand enhances intracellular entry and 
increases response to intracellular release of therapeutic peptide into the cells(Kumar, Ma et al. 2012). 
Besides small molecules (amines and peptides), some proteins such as antibodies, have been 
also used to label gold nanoparticles for cell biology studies. El-Sayed(El-Sayed, Huang et al. 
2005) and his co-workers used Surface Plasmon Resonance (SPR) and dark field microscopy 
to track the binding between anti-EGFR (anti-epidermal growth factor receptor) antibodies 
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conjugated gold nanoparticles and cells. Conjugated GNPs were able to bind specifically and 
homogeneously to the surface of cancer cells and non-cancerous cells with a maximum 
absorption at 545nm and 552nm respectively. Light scattering images showed that conjugated 
nanoparticles bind specifically to cancer cells and this makes the anti-body GNPs conjugates 
potentially usable in cancer diagnostics. They also found that benign cells, after incubation 
with anti-EGFR antibody conjugated GNPs, require double laser energy to be killed than 
malignant cells(El-Sayed, Huang et al. 2006).  This finding is promising in molecularly 
targeted photothermal therapy.  
1.1.3 Functionalized gold nanoparticles as biosensors 
 
Gold nanoparticles biosensors are used to recognize the presence of analytes and to provide a 
way which indicates the analyte concentration, typically based on optical properties. Changes 
of GNPs optical properties can be recorded by various methods, in this section, we introduce 
three commonly used tools: the colour change of GNPs solution is observed by naked eyes, a 
fluorophore can be quenched by approaching GNPs, GNP dimers can enhance Raman 
scattering signal. 
Colorimetric Sensors 
Surface plasmon resonance (SPR) is one of the optical properties of GNPs which can be used 
for biosensors. The biomolecular binding to GNPs surfaces can change the SPR, resulting in a 
spectral shift which can be observed, for example, by dark field microscopy(Raschke, Kowarik 
et al. 2003). The interactions between protein/DNA-modified GNPs could form aggregates 
which also leads to colour change of GNPs solutions. This colour change is developed for 
colorimetric biosensors which can be easily read out with naked eyes. 
Mirkin and co-workers are the pioneers of GNPs-based colorimetric biosensors. The earliest 
colorimetric sensor was used for DNA detection. GNPs were attached to oligonucleotides 
which were used to hybridize to target sequences. Without the target oligonucleotides, GNPs 
were well dispersed and the solution appeared in red colour. In the presence of target 
oligonucleotides, the GNPs were brought closely in contact by hybridization of complementary 
oligonucleotides, resulting in aggregation which lead to the colour change from red to purple 
or blue.  
Two batches of 13nm GNPs were attached with non-complementary DNA oligonucleotides 
capped with thiol groups. The oligonucleotide duplex with ‘sticky ends’ that are 
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complementary to the two grafted sequences triggered the self-assembly of GNPs into 
aggregates(Mirkin, Letsinger et al. 1996). This assembly can be reversed by thermal 
denaturation.  
It is known that Hg2+ leads to thymidine-thymidine mismatch in DNA hybridization (Miyake, 
Togashi et al. 2006). Mirkin group prepared two sets of GNPs which were conjugated with 
different thiolated-oligonucleotides which are complementary except for a single thymidine-
thymidine mismatch(Lee, Han et al. 2007). The Hg2+ triggered the hybridization between 
thymidine and thymidine result in the aggregation of GNPs, consequently, the red GNPs 
solution turn into purple (Figure 1.6). This was proposed as a biosensor to detect presence of 
Hg2+ 
 
Figure 1.6 Colorimetric detection of mercuric ion (Hg2+) using DNA–Au NPs(Lee, Han et al. 2007). 
A colorimetric sensor for multi-metal ions detection was also demonstrated. GNPs were 
functionalized with Flag-A3 peptide (-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys-Pro-Ala-Tyr-Ser-
Ser-Gly-Pro-Ala-Pro-Pro-Met-Pro-Pro-Phe-)(Slocik, Zabinski et al. 2008). The A3 peptide 
domain (-Ala-Tyr-Ser-Ser-Gly-Pro-Ala-Pro-Pro-Met-Pro-Pro-Phe-) binds to GNPs. The Flag 
tag at the amino terminus of the peptide (-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys-) contains 
charged and aromatic residues that can form the complexation of metal ions(Slocik and Naik 
2006). The GNPs-peptide conjugates gave different SPR peaks due to the addition of metal 
ions such as Co2+, Hg2+, Pb2+, Pb4+ and Pt2+. 
Fluorescence quenching 
Fluorescence is quenched when the fluorophores have a close distance to gold nanoparticles. 
The quenching between GNP and fluorophores is described as Fluorescence Resonance Energy 
Transfer (FRET), and is based on a non-radiative energy transfer between the donor 
(fluorophore) and the acceptor (GNP)(Clapp, Medintz et al. 2006). There are two typical 
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biosensor strategies based on this interesting feature. The first strategy is a competitive format 
for the analyte detection. GNPs are attached with ligands that could be recognized by the 
analyte. The binding sites of ligands are blocked by molecules which are labelled with 
fluorophores. In this case, the fluorophores are close to GNPs surfaces so that the fluorescence 
is quenched. After the addition of the analyte, the fluorophore molecules are replaced and 
released from GNPs into solution. Since the fluorophore is far from the GNPs, the fluorescence 
emission becomes visible. Basically, the more analyte is present in the solution, the higher the 
fluorescence will be. Quantum dots (QDs) are a new class of fluorescent materials that are 
efficiently quenched by GNPs. QDs FRET quenching is widely used for DNA detection 
(Figure 1.7). A QD tagged receptor DNA was hybridized with a short DNA sequence attached 
to a GNP. The fluorescence of QD was quenched by the GNP. A target DNA which 
complements the receptor DNA better would be able to displace the short DNA-GNP element. 
Consequently, the QD would be  released into solution and the fluorescence could be measured 
(Zhao, Zhang et al. 2007). | 
 
Figure 1.7 Illustration of FRET quenching between GNP and Quantum Dots (QD) for DNA detection(Holzinger, Le Goff 
et al. 2014). 
Another strategy is achieved by controlling the distance between the fluorophore and GNPs. 
The target analyte is used to adjust the distance. A new method for microRNA analysis based 
on the fluorescence quenching of GNPs integrating a hairpin-structured oligonucleotide probe 
was reported(Tu, Wu et al. 2012). The Fluorescein isothiocyanate (FITC) labelled probe DNA 
had a stem-loop which brings the fluorophore close to GNPs to quench the fluorescence. The 
addition of miRNA resulted in hybridization with the probe DNA and stretching of the stem-
loop. This brought the FITC away from GNPs, hence the fluorescence was recovered.  
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Surface-enhanced Raman scattering 
Raman scattering has a low energy component (Stokes, by depositing energy into the molecule) 
and a high energy one (anti-Stokes, by gaining energy from the molecule). The energy shift 
depends on the chemical structure where the scattering occurred and complex molecules have 
therefore a characteristic Raman spectrum that allows for detection and identification(Sperling, 
Gil et al. 2008). However, the Raman signal is very weak, so the sensitivity of detection is low. 
It was found that molecules which decorate rough noble metal surfaces provide enhanced 
Raman scattering signal(Campion and Kambhampati 1998). This phenomenon is known as 
Surface-enhanced Raman scattering (SERS). 
In SERS the laser-generated Raman spectrum of a substance, which can be used to determine 
the identity of the analyte, is enormously amplified by the proximity of gold or silver 
nanoparticles(Nie and Emory 1997). The gap between two gold nanoparticles which form a 
dimer was also discovered to generate SERS signals(Alexander, Hampton et al. 2009). In 
certain circumstances, the signal intensity was increased over 1 billion times, making the 
detection of single molecules possible. The dimers that can be considered the closest to a 
practical use where manufactured and characterised by Korean scientists(Lim, Jeon et al. 2010). 
These objects are called nano-dumbbells: two gold nanoparticles were assembled together 
simply using complementary strands of DNA on each particle; a Raman-active Cy3 dye 
molecule was chemically bound to the DNA linker for single-molecule SERS generation. This 
study reported the first evidence of single molecule SERS detection from a single Cy3 molecule 
trapped in the gap between two gold nanoparticles.   
1.1.4 Functionalized gold nanoparticles for delivery 
 
Gold nanoparticles have been playing an important role in biological delivery for decades. 
Because of conjugated molecules, such as amino acids, peptides or antibodies, functionalized 
GNPs are able to recognize specific targets in cells, such as cancer cells and nucleus. The 
interaction between functionalized GNPs and human cells are regarded as biocompatible and 
non-toxic(Connor, Mwamuka et al. 2005). GNPs are used as carriers into cells either for gene 
delivery or drug delivery.  
Gene delivery 
Amine labelled GNPs provide a way to deliver DNA into cells. Gold nanoparticles are 
functionalized with lysine and lysine dendron formed particularly compact complexes and 
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provided highly efficient gene delivery without any observed cytotoxicity(Ghosh, Kim et al. 
2008). Lysine coated GNPs could form salt bridges with the phosphate backbone of DNA(Voet 
and Voet 1995) which was referred as to nanoplex (Figure 1.8). The nanoplex transfected into 
mammalian cells while the naked DNA could not. Moreover, the conjugation of lysines on 
gold nanoparticles in a dendritic fashion yielded efficient vectors which are about 28-fold more 
efficient than polylysine for in vitro transfections. 
 
Figure 1.8 GNP biosensor for gene delivery. Schematic illustration of the monolayer protected gold nanoparticles used as 
transfection vectors in this study. DNA is condensed by lysine-coated GNPs and able to be transfected into mammalian 
cells. 
To achieve targeted gene delivery in human cells, the carried gene should be stable in blood 
and released at the target site. Niidome’s study shows that PEG-modified nanoparticles 
maintained DNA more stably in the blood than the naked DNA, and DNA was released and 
passed through cellular membranes via the control of electrical pulses in a restricted area of 
liver(Kawano, Yamagata et al. 2006). Mirkin’s group demonstrated that antisense DNA 
functionalized GNPs can down-regulate EGFP expression in C166, a mouse endothelial cell 
line(Rosi, Giljohann et al. 2006). For this purpose, GNPs were conjugated to either tetrathiol-
modified or monothiol-modified antisense oligonucleotides and the latter modification had a 
~35-fold higher binding affinity to gold, which resulted into better delivery of DNA into cells. 
Drug delivery 
The biocompatibility of gold nanoparticles has been exploited for drug delivery. GNPs can be 
synthesized to minimize non-specific binding to biomacromolecules. In a recent study, GNPs 
were produced with a n-alkyl disulphide layer which is a zwitterion (Rouhana, Jaber et al. 2007) 
or additional groups to the zwitterion layer: a hydrophobic interior layer of alkanethiol and a 
hydrophilic shell composed of a tetraethylene glycol unit (Kim, Ghosh et al. 2009). These 
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modified GNPs were reacted with three different hydrophobic compounds: a fluorescent probe, 
Bodipy, the therapeutic tamoxifen and the drug β-lapachone (Figure 1.9). The Bodipy was 
initially quenched by GNPs, while the fluorescence was switched on after the dyes/drugs were 
released into cells by membrane-mediated diffusion without uptake of the carrier GNPs.  
 
Figure 1.9 GNP biosensor for drug delivery. Delivery of drugs to cells through monolayer-membrane 
interactions(Kim, Ghosh et al. 2009). 
The above strategy is based on non-covalent binding which allows the easy release of drugs, 
however, premature release is an issue. Covalent binding to GNPs, for example through sulphur 
or sulphydric groups, provides a stable delivery vehicles for drugs.  
Covalent binding has been also applied to vaccine delivery. Chitosans were covalently 
combined to GNPs (Chito-GNPs), and the Chito-GNPs conjugates were used as vectors for the 
delivery of plasmid DNA vaccine in vitro and in vivo(Zhou, Zhang et al. 2008). Chito-GNPs 
conjugates were delivered by intramuscular immunization into BALB/c mice resulting in 10-
fold enhancement of serum antibody response compared to naked DNA vaccine. 
1.2 Modular Protein Assembly 
 
Proteins are structurally complex molecules that makes it difficult to find a unique and proven 
crosslinking method which consistently and efficiently produces functional NPs conjugates, 
regardless of the specific protein. Hence, immobilization has to be optimized according to 
specific conditions. For instance, proteins containing cysteine residues can be chemically 
bound to GNPs through Au-S bond, unfortunately, the adsorbed proteins are in a high risk to 
be denatured(Laera, Ceccone et al. 2011). In this project, we propose the use of “sacrificial” 
intermediates that bind efficiently to GNPs and carry a domain, either chemically cross-linked 
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or recombinantly fused, which is able to bind another protein. This protein will not be affected 
by the NP surface, which is passivated by the sacrificail intermediate, and can be used as an 
affinity tag for easy binding of potentially any protein of interest, without any need of protein-
surface optimization steps. In this project, we used Glutathione-S-Transferase (GST) and 
Bovine Serum Albumin (BSA)as the intermediate proteins to adsorb on the GNP surfaces and 
form the protein corona (sacrificial layer). We used two pairs of proteins, SNARE proteins and 
SpyTag/SpyCatcher as affinity systems. We investigated the ability of affinity systems to form 
complexes while adsorbed on GNPs through GST or BSA.   
1.2.1 SNARE Proteins 
 
Neuronal SNAREs (soluble N-ethylmaleimide-sensible factor attachment receptor proteins) 
are the main proteins involved in synaptic vesicle exocytosis. SNAREs exist in many isoforms 
involved in trafficking, and the neuronal SNAREs are the most studied and they are the system 
from which the SNAREs in this study are derived from. Neuronal SNAREs are namely 
Syntaxin 1, SNAP25 (Synaptosomal-associated protein 25) and Synaptobrevin 2 (Figure 1.10A) 
and their function is to mediate the fusion of synaptic vesicles to the cell membrane at the 
synapses, with subsequent release of neurotransmitter in the synaptic cleft (Figure 1.10C). Part 
of the sequences of Syntaxin 1 and Synaptobrevin 2 anchor them to the cell membrane and the 
vesicle membrane respectively (transmembrane domains). SNAP25 is linked to the cell 
membrane through 4 palmitic acids bound to 4 cysteine residues on the loop that separates two 
SNARE domains. The fast interaction between the SNAREs bound to the plasma membrane 
and the Synaptobrevin bound to the synaptic vesicle triggers the fusion of the membranes 
(Figure 1.10B).  
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Figure 1.10 SNARE proteins (A) their mechanism of action (B) and an electron micrograph of a synapse (C). The two 
arrows indicate vesicles undergoing fusion. Figures rehashed from(Jahn and Scheller 2006) and (Torri-Tarelli, 
Grohovaz et al. 1985, Jahn and Fasshauer 2012). 
The SNARE complex that forms and drives membrane fusion is structurally a coiled-coil of 4 
helices named SNARE domains. Syntaxin and Synaptobrevin contribute 1 helix each, SNAP25 
contributes 2. The hydrophobic residues of the SNARE motifs are oriented inward to form the 
hydrophobic layers of the coiled-coil like in classical leucine zippers(Fasshauer, Sutton et al. 
1998) (Figure 1.11A). However, the layer in the middle of the complex, called the “0” layer or 
“ionic” layer, is formed by ionic interactions between an arginine (Synaptobrevin) and three 
glutamines (Syntaxin and SNAP25) (Figure 1.11B). For this structural feature common to all 
SNAREs isoforms, often the SNARE domains are classified as Q- or R-SNAREs depending 
on the residue they contribute to the “0” layer(Bracher, Kadlec et al. 2002). The SNARE 
complex is so stable that partially resists to the deanturing condition of SDS-PAGE and can be 
only disassembled in boiling SDS-PAGE loading buffer containing sodium dedocyl sulfonate 
(SDS)(Fasshauer, Antonin et al. 2002).  
 
 
A 
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Figure 1.11 The backbone of the SNARE complex. (A) The C-termini are at the right, while the N-termini are at the left. 
The hydrophobic amino acids face to the center of the helix. The backbone of Syntaxin is highlighted in red, 
Synaptobrevin in blue and the SNAP25 two SNARE domains in green. The zero layer is outlined in red while the 
hydrophobic layers are black. (B) The zero layer shown as a section. Figures a and b are from(Fasshauer, Sutton et al. 
1998, Bracher, Kadlec et al. 2002). 
In vitro, syntaxin and SNAP25 can form a stable complex containing two syntaxin molecules, 
one of which is occupying and possibly obstructing the binding site of synaptobrevin(Fasshauer 
and Margittai 2004). It has been found that syntaxin and synaptobrevin can also be assembled 
in vitro without SNAP25(Fix, Melia et al. 2004), however the most stable complex is given by 
the hetero-trimer. 
It is important to mention that the SNARE complex forms in the direction of N- to C- terminal. 
To show this, mutations were conducted in the N- and C- terminal. Mutations in the N-terminal 
slowed the fusion, in contrast, C-terminal mutations had no effects on SNARE 
assembly(Sørensen, Wiederhold et al. 2006). Based on this fact, in this project, the introduction 
of a cysteine in Syntaxin and Synaptobrevin for conjugation purpose, was deliberately  at the 
C-terminal. We used SNAREs, either cysteine-linked through Sulfo-SMCC to BSA or 
recombinantly fused to GST, to assess their ability to modularly bind upon adsorption on NPs. 
1.2.2 SpyCatcher/SpyTag proteins 
 
In most proteins, including SNARE proteins, the forces that stabilise complexes are non-
covalent, such as hydrophobic, ionic interactions and hydrogen bonds(Kang and Baker 2011). 
Disulphide bonds are the only well-known covalent bonds in protein-protein complexes. 
A 
B 
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Disulphide bonds form between two cysteine residues and has been proven that these can 
stabilize proteins against thermal unfolding(Hagihara, Mine et al. 2007), suggesting that they 
contribute to intramolecular stability. In the major pilin subunit from the Gram-positive human 
pathogen Streptococcus pyogenes, Baker’s group found a new intermolecular covalent bond of 
proteins, between a carboxyl terminal and the amino group of a lysine of the next molecule, 
which is referred to as isopeptide bonds(Kang, Coulibaly et al. 2007). Isopeptide bonds have 
the same structure of peptide bonds, however, they have the following features(Kang and Baker 
2011): 
1. the majority of the reactions occur between a lysine ɛ-amino group on one protein and 
a main chain α-carboxyl group on another protein;  
2. the formation is enzyme-mediated, and involves a transient thioester intermediate 
formed by a cysteine on the active site of a participating enzyme; the intermediate is 
then reacted through nucleophilic attack by the lysine ɛ-amino group to achieve an 
isopeptide bond. 
Recently, Howarth and his colleagues explored the immunoglobulin-like collagen adhesion 
domain (CnaB2) which contains a single isopeptide bond (Figure 1.12A)(Zakeri, Fierer et al. 
2012). Interestingly, this is an intramolecular isopeptide and its formation is self-catalysed. 
Due to this unique features, CnaB2 was splitted into two poly-peptides, followed by rational 
modification, to assess whether it was possible to obtain an intermolecular isopeptide bond 
formation from the split protein, with potential applications in bio-conjugation. The group 
produced a peptide tag of 13 amino acids, SpyTag, able to form an isopeptide bond with its 
protein partner of 138 amino acids, SpyCatcher (Figure 1.12B)(Zakeri, Fierer et al. 2012). The 
name Spy comes from the fact that the original protein is found in invasive strains of 
S.pyogenes(Oke, Carter et al. 2010). The peptide bond formed by SpyTag and SpyCatcher is 
so stable that could remain folded in extreme pH (pH2) and high temperature (up to 100°C) 
conditions(Hagan, Björnsson et al. 2010). 
17 
 
         
Figure 1.12 Isopeptide bond structure (A) the isopeptide bond formation between SpyTag and SpyCatcher. (B) 
construction of SpyTag and SpyCatcher from S.pyogenes (Spy): CnaB2 was dissected into a large N-terminal fragment 
(SpyCatcher, left) and a small C-terminal fragment (SpyTag, right). Reactive residues are highlighted in red(Zakeri, 
Fierer et al. 2012). 
SpyTag and SpyCatcher can rapidly form covalent bonds without adding enzymes and are 
powerful bio-conjugation tools. We used this pair of proteins to study interactions of GNPs and 
protein. GST was fused to SpyCatcher to form a sacrificial layer adsorbed on GNPs and we 
demonstrated its ability to bind SpyTag directly on the GNP surface. 
 
1.3 Recombinant Synthesis of Protein 
 
Recombinant proteins are identified as proteins encoded by a gene that is cloned in an organism 
which supports the gene expression and messenger RNA translation. The gene normally does 
not exist in the genome, but could be synthesized by laboratory methods such as cloning. 
Following cloning into a host vector, the recombinant DNA could be expressed and the 
recombinant protein is produced. Finally, the purification process is introduced to harvest the 
proteins from the host organism. In the context of this work, we made extensive use of designer 
recombinant proteins for the decoration of GNPs.   
1.3.1 Cloning 
 
Cloning is a technique that generates a target DNA sequence containing a gene or a DNA 
fragment of interest, combines it to an appropriate replicon in vitro, then insert it into a host 
organism such as plasmid, finally express the gene by the host. Here, we summarize the cloning 
procedure into five steps: 
Generation of target DNA insert.  
A B 
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The target DNA sequence can be generated in various ways, including polymerase chain 
reaction (PCR), chemically synthesizing DNA, cutting the DNA from existing fragments by 
restriction enzymes, primer extension and annealing. The two main ways to obtain the insert 
DNA are PCR and the use of restriction enzymes to cut the insert DNA from vectors, which 
were both used in this work. The PCR process quickly and easily amplifies the target DNA 
sequence and adds through the primers the restriction sites to the ends of DNA, so it can be 
inserted into a plasmid. Primers are designed based on the existing DNA sequence or public 
DNA database. If the target DNA exist in other DNA fragments, it could be separated by 
restriction enzymes and directly sub-cloned into the destination vector. To ensure that the insert 
DNA are kept in the frame, the selection of restriction sites and vectors have to be carefully 
checked. The full sequence including the insert DNA and vector can be mapped by using online 
resource such as http://web.expasy.org/translate/. 
Preparation of the expression vectors by restriction endonucleases.  
Before the ligation, the vector is digested by restriction enzymes to obtain the compatible 
overhangs with the generated target DNA. Expression vectors, and more generally all vectors 
engineered for the purpose of cloning, have a multiple cloning site specifically design for the 
convenient insertion of a digested fragment. This includes many standard restriction sites all in 
close proximity, with good chances that their position matches a desired design. In expression 
vectors the cloning site is under a promoter that promotes expression of the inserted fragments. 
Restriction enzymes that generates overhangs upon digestion are generally preferred, unless 
there are reasons to prefer blunt ligation (for example routine cloning of chemically synthesised 
inserts by companies that provide custom gene synthesis). Digestion with two restriction 
enzymes that generates two different overhangs is also favourable, as it guarantee correct 
orientation and prevents self-ligation of the vector compared to the case of a single restriction 
enzyme. In the case that the vector is cut by a single restriction enzyme, the insert could anneal 
in both orientation, in an undefined number of copies and the ends may be able to be religated. 
To prevent this, the vector should be treated with alkaline phosphatase.   
Ligation of the target DNA and digested vector.  
Ligation is accomplished by simply mixing the target DNA and vectors which are digested 
with identical or compatible restriction enzymes. The overhangs are annealed through 
hydrogen bonds between bases and the phosphodiester linkage is catalysed by ligase, such as 
T4 DNA ligase, and the ligation is conducted in T4 DNA ligase buffer containing ATP. 
Transformation of completed vector and screening.  
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E.coli is commonly used to take up the completed DNAs and was the host of choice for all the 
recombinant proteins in this work. The transformants are spread on the plate of selective media 
(containing antibiotics) on which only the completed vectors which include a gene for 
antibiotic resistance could grow. Following the transformation into E.coli, the colonies carrying 
recombinant vectors are screened by gel electrophoresis of the vectors digested by restriction 
enzymes, for selecting those with the correct DNA insert. Alternatively, screening can be 
further simplified by choosing a vector and E.coli strains that are compatible with blue/white 
screening, which take advantage of intracistronic α-complementation to regenerate β-
galactosidase activity. 
Verification of the DNA insert by sequencing.  
The target DNAs have a risk for mutation during the process, especially if PCR is involved. 
Because of this, the recombinant vectors that result positive after the screening, are typically 
Sanger-sequenced to determine the final sequence, generally using standard primers that anneal 
near the 5’ or 3’ ends of the multiple cloning site of the vector. 
1.3.2 Expression 
 
Expression vectors typically include a promoter that promotes the transcription and subsequent 
translation of the insert and repressors such as lac,that take control of the expression only in 
presence of an inducer molecule. Often, the protein of interest is fused to an affinity tag encoded 
directly into the vector, like in the case of the expression plasmid pGEX-KG used in this work, 
which is meant for the expression of C-terminal fusion to Glutathione-S-Transferase (GST). 
This facilitates the purification of the protein by using glutathione modified resins for which 
the fusion protein has high affinity. The affinity tag can be either removed proteolitically or 
retained. Another common affinity tag in expression vectors, for example the pET family, is 
represented by His-tag, which has high affinity to nickel bound to resins(Gibert, Bakalara et al. 
2000).  
In vivo and vitro are the two methods that can be used for recombinant protein expression. The 
in vivo expression is the well-established strategy for recombinant protein expression through 
transfecting cells with the DNA vector which contains the gene of desire protein. During the 
cell culture, the gene is transcribed and translated to proteins. The subsequent purification is 
followed to extract proteins from the cell lysate. Some of the bacterial, such as Escherichia 
coli, have the ability to express recombinant protein in a large quantity so that it is used in 
industrial process and the development of commercial goods(Rosano and Ceccarelli 2014). 
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However, muli-domain eukaryotic proteins have a high risk of losing the function in bacteria 
expression because cells are not equipped to reach the requirement of post-translational 
modifications or molecular folding(Chang, Kaiser et al. 2005). Eukaryotic protein domains, 
such as the SNARE domains used in this work, are suitable for expression in bacteria when 
post-translational modifications are not required, they are largely unstructured and therefore do 
not have critical folding. They have been successfully expressed in E. coli for at least two 
decades and this work makes use of well-established and biochemically well-characterized 
SNAREs(Chapman, An et al. 1994).   
Cell-free protein expression is a new developed in vitro strategy of proteins offering a simply 
and quickly method in a quasi-cell environment that makes use of purified enzymes and cell-
extracts for transcription and translatio. The cell-free system has various advantages than cell 
based expression (invivo): time-saving (24-48 hours for protein expression), the ability to adapt 
to high-throughput formats, increased tolerance to additives and less sensitivity to toxic or 
proteolytic proteins(Arduengo, Schenborn et al. 2007). However, it is only suitable and cost-
effective for limited amounts of protein, compared to the in vivo alternatives. Therefore cell-
free systems were not considered as an option for this work, which required significant yields 
of expressed proteins for their use in chemical modification steps.  
 
1.4 Protein chemical crosslinking 
 
Protein chemical crosslinking provides a method of combining two or more proteins through 
covalent bonds by using one or more of the reactivities explained above in the form of 
crosslinkers (CL). CL typically are directed towards sulfhydryls, primary amines and carboxyls. 
CL are either homobifunctional or heterobifunctional molecules depending on whether they 
offer identical or different reactive groups respectively. Generally, the homobifunctional CL 
are used to react with primary amine groups (lysine residues) or sulfhydryls (cysteine residues). 
However, the main issue of homobifunctional CL is their susceptibility to produce undefined 
or undesirable conjugates. Controlling a reasonable concentration ratio of the two target 
proteins is difficult. Under the wrong concentration conditions, the active proteins combine 
with the proteins themselves forming the undesirable intra-protein crosslinking between the 
same proteins leading to low productivity of expected protein conjugates. If the two target 
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proteins have similar molecular weights, then it is difficult to separate the intra-protein 
crosslinking from expected protein conjugates.  
The heterobifunctional CL is employed to combine proteins through different functional 
groups, such as a sulfhydryl and an amine group, or an amine and a carboxyl group. In these 
crosslinking reactions, the process normally consists of two steps to maximize the amount of 
protein conjugates. First, the CL reacts with one of the protein to form an activated protein or 
an intermediate, then the excess CL is removed. Second, the activated protein is incubated with 
the other protein for making conjugates. For example, SMCC (succinimidyl trans-4-
(maleimidylmethyl) cyclohexane-1-carboxylate) is a CL for linking sulfhydryl and an amine 
groups through the maleimide and NHS (N-hydroxysuccininmide) ester respectively. The NHS 
ester reacts with amine groups of one protein first and after removing the excess SMCC, the 
other protein containing sulfhydryls are added to the activated protein. 
Primary amines (-NH2) exist at the N-terminals of peptides and the side chains of lysine 
residues. CL reagents providing reactive acylating groups are widely used for crosslinking of 
primary amines, such as NHS esters and imidoesters. The NHS ester reacts with primary 
amines in mildly alkaline conditions to form amide bonds and release NHS groups(Lomant and 
Fairbanks 1976). The high alkaline condition increases the hydrolysis of NHS ester, therefore, 
pH7.2 to pH8.0 is an important condition (Hermanson 1996). Sulfo-NHS ester is similar to 
NHS ester except that it has a sulfonate (-SO3) on the NHS ring. The sulfonate group has no 
effect on the reaction between primary amines and ester, but it increases the solubility of the 
CL in aqueous buffers. The NHS ester is able to react with sulfhydryls and hydroxyls, however, 
the products are not stable because they are hydrolysed quickly in aqueous buffers(Hermanson 
1996).   
The imidoester is the most specific acylating reagent to modify amines. Compared to NHS 
esters, the imidoester crosslinkers perform better at higher alkaline conditions. At a pH below 
8, the half-life of hydrolysis is short, at a pH of 10, the half-life and reactivity with primary 
amines increases. Moreover, the side reactions are negligible at pH=10(Browne and Kent 1975).  
The carbodiimide is a special CL which does not introduce space chains into proteins and, as a 
consequence, the conjugates combined by carbodiimide groups are spatially close. 
The modification and crosslinking of sulfhydryl are achieved by maleimide reactions. The 
maleimide groups specifically react with sulfhydryls at a pH of 6.5-7.5(Partis, Griffiths et al. 
1983). At pH>8, the maleimide reacts with primary amines quicker than sulfhydryl, and the 
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maleimide are hydrolysed to maleamic acid which is non-reactive with sulfhydryl. 
Nevertheless, maleimide groups have no activity with carboxyl, hydroxyl or any other 
functional groups.    
1.5 Proteins conjugation to gold nanoparticles 
 
The layer of biomolecules that covers GNPs is called corona and it forms upon the interaction 
of GNPs with biological sources. In section 1.1, we introduced that GNPs can be decorated by 
amino acids, peptide, nucleic acids and proteins. Functionalized GNPs are useful tools for 
biological applications, such as gene and drug delivery and biosensors.  
Since the research in my project focuses on the interaction between proteins and GNPs, here 
we introduce proteins adsorption onto gold nanoparticle surfaces.  
1.5.1 GNP-protein binding 
 
The Vroman effect suggests that at the early stage of the interaction of nanoparticles with 
biological fluids, most abundant proteins are adsorbed onto nanoparticles, however, after hours’ 
incubation, the subsequent protein-protein competition shows they are replaced by higher 
affinity proteins(Vroman, Adams et al. 1980). The high affinity adsorption is also known as 
the ‘hard corona’, while the low affinity proteins form a ‘soft corona’ surrounding NPs. From 
the physical-chemical point of view, the hard corona is a long-lived structure that needs several 
hours to be exchanged (Monopoli, Walczyk et al. 2011). Another hypothesis is that hard corona 
proteins interact with NPs directly forming tightly bound proteins that do not readily desorb, 
and the soft corona proteins interact with the hard corona through weak protein-protein 
interactions(Walkey and Chan 2012). 
According to the way proteins interact with NPs, the binding is defined in three ways: 
physisorption, nonspecific chemisorption and selective orientation-controlled adsorption. 
Practically the selective orientation-controlled adsorption is the only promising way that 
preserves the proteins’ biological functions, whereas the other two lead to unpredictable results.  
In physisorption the protein structures are largely distorted and the protein functions are 
compromised (Torcello-Gómez, Santander-Ortega et al. 2011). The reason for this effect is that 
interactions involved in the physisorption are the same factors that affect protein stability and 
structures, such as hydrophobic, electrostatic and hydrogen bonding(Avvakumova, Colombo 
et al. 2014). Nonspecific chemisorption is a stronger interaction than physisorption, because 
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proteins become conjugated to NPs by covalent binding, which is permanent. This approach is 
often achieved by modifying the NPs with functional groups including amine, thiol and 
carboxyl. The most commonly used chemistry is Au-S as we described in section 1.1. However, 
despite sulfhydryls can be precisely localised on a protein structure, most of the chemisorption 
poorly control the orientation of interactions.  
To control the protein orientation on NP surfaces, there are three important requirements 
(Avvakumova, Colombo et al. 2014): 
(1) A tight irreversible linkage to reduce the system free energy. 
(2) Site-specific binding. 
(3) Controlled spatial orientation of the biomolecule to make all ligands active.  
Based on the above rules, several developed methods exploited specific interactions including 
the use of biological counterparts(Yang, Mao et al. 2009) and chemical ligands(Hou, Qiao et 
al. 2012). All these methods improved the control of orientation, however, the modifications 
required on proteins decreased the biological activity resulting in activity impairment(Mahon, 
Salvati et al. 2012). 
A new approach has been developed here to achieve the selective orientation-controlled 
adsorption. Bovine Serum Albumin (BSA) and Glutathione-S-Transferase (GST) have been 
linked to target proteins, either by chemical crosslinking (BSA) or recombinant fusion (GST). 
BSA and GST have been used as intermediates to bind GNP surfaces by chemisorption. Whilst 
BSA and GST firmly bind GNPs, the target proteins (SNARE proteins and SpyTag/SpyCatcher) 
are not directly involved in the chemisorption and still maintain their biological activities and 
are potentially able to selectively bind other molecules. The details of SNARE proteins and 
SpyTag/SpyCatcher are introduced in section 1.5. 
1.5.2 Physicochemical study of the GNP-Protein binding 
 
From the physicochemical point of view, the adsorption of proteins to nanoparticles follows an 
equilibrium where proteins adsorb and desorb to the NPs surfaces. The reaction is in 
equilibrium when concentrations do not change. In this project, the Hill equation was used to 
set a simple model for the adsorption of proteins to GNPs(Hill 1910). The adsorption can be 
described as below: 
M + S                 MS     (Equation 1.1)  
Kon 
Koff 
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In the equation 1.1, M is the molecule that binds to a free site S on the surface of GNPs, MS is 
the site occupied by the protein, and Kon is the association constant and has the molar unit (M-
1·s-1), Koff is the dissociation constant and has the molar unit (s-1). According to the law of mass 
action of Waage and Guldberg(Waage and Guldberg 1964): 
                          
𝑑[𝑀𝑆]
𝑑𝑡
= [𝑀] ∙ [𝑆] ∙ 𝐾𝑜𝑛 − [𝑀𝑆] ∙ 𝐾𝑜𝑓𝑓 = 0   (Equation 1.2) 
The equilibrium dissociation constant (KD) is defined as: 
𝐾𝐷 =
𝐾𝑜𝑓𝑓
𝐾𝑜𝑛
=
[𝑀]∙[𝑆]
[𝑀𝑆]
        (Equation 1.3) 
The maximum surface adsorption [SMAX] is the sum of the free surfaces of GNPs and the 
adsorbed surfaces: 
                                                     [𝑆𝑀𝐴𝑋] = [𝑆] + [𝑀𝑆]       (Equation 1.4) 
The equation 1.3 and 1.4 are rearranged to define [MS]: 
                                                          [𝑀𝑆] = [𝑆𝑀𝐴𝑋]
[𝑀]
𝐾𝐷+[𝑀]
         (Equation 1.5)        
This model assumes that a molecule M binds to a free site S is not interacting with already 
occupied sites and that the proteins form a monolayer (single occupancy of the free sites S).  
The concentration of the molecule [M] is the independent variable, whereas the concentration 
of the bound molecules [MS] is not directly measurable, but it is proportional to the measurable 
increase in diameter d of the nanoparticles (Δd), for example by Dynamic Light Scattering 
(DLS). Similarly, [SMAX] is proportional to the maximum measurable diameter increase 
(ΔdMAX) in such a way that: 
[MS] [𝑆𝑀𝐴𝑋]⁄ = ∆𝑑 ∆𝑑𝑀𝐴𝑋⁄  
This is again only valid under the assumption that a monolayer forms all around the 
nanoparticle (known as corona). The equation 1.5 then becomes: 
∆𝑑 = ∆𝑑𝑀𝐴𝑋
[𝑀]
𝐾𝐷+[𝑀]
 (Equation 1.6) 
This is the equation that was used in this project to experimentally determine the binding 
affinity of a protein to NPs by using DLS data (Δd and ΔdMAX) acquired at different 
concentrations [M]. 
25 
 
Based on IUPAC’s Gold Book(McNaught and McNaught 1997), the definition of reaction rate 
is: 
               
𝑑[𝑀𝑆]
𝑑𝑡
= −𝐾 ∙ [𝑀𝑆]            ln⁡[𝑀𝑆] = ln⁡[[𝑀𝑆]𝑀𝐴𝑋] − 𝐾𝑡    (Equation 1.7) 
K is the rate constant. In my project, [MS]MAX is proportional to the maximum diameter 
increased (ΔdMAX), and [MS] is proportional to the size increase of GNPs (Δd), hence equation 
1.7 is rearranged as: 
∆dMAX = ∆d(1 – e-Kt) (Equation 1.8) 
Therefore, from the same experimental data used to calculate KD it is also possible to determine 
the rate constant K. 
1.5.3 Parameters affecting protein corona   
 
According to the above section, we have tools to understand how proteins are adsorbed onto 
GNPs surfaces. However, more and more researchers are working on exploring the parameters 
affecting the protein corona. Lundqvist and colleages studied the hard corona formed from 
human plasma for NPs with different size and surface properties(Lundqvist, Stigler et al. 2008). 
This shows that many of highly abundant proteins, regardless of size and surface charge, all 
form part of the corona. However, there are various parameters that are important,  
hydrophobicity, surface charge and NPs size are the three most relevant factors that affect the 
corona formation. In the following description, each parameter will be given a detailed 
explaination.  
Hydrophobicity  
NPs with hydrophobic surfaces can adsorb more protein, as evidenced by gel filtration 
experiments (Cedervall, Lynch et al. 2007, Treuel, Brandholt et al. 2014). Human serum 
albumin (HSA) was incubated with different hydrophobic NPs and the amount of HSA 
adsorbed was evaluated by the elution volume and intensity of the peak corresponding toHSA-
NPs conjugates. It was shown that the most hydrophobic NPs gave the largest conjugates, 
which had the highest peak and went out the column first.  
The adsorption of protein onto hydrophobic and hydrophilic NPs was also compared. The 
surfaces with hydrophobic or hydrophilic features were controlled via the ratio between co-
monomers N-iso-propylacrylamide/N-tert-butylacrylamide ( the ratio of 100:0 giving the most 
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hydrophobic NPs). After incubation with HSA, the most hydrophobic NPs were fully covered 
with a single layer of proteins, while, the hydrophilic NPs were barely adsorbed with 
HSA(Lindman, Lynch et al. 2007). 
Surface Charge 
The surface charge of NPs plays an important role in protein adsorption. It is a general 
preference that proteins with isoelectric points (pI) >5.5 adsorb onto negative NPs surfaces 
bearing acidic functional groups (Gessner, Lieske et al. 2003), whereas proteins with pI less 
than 5.5 are preferentially adsorbed to positive charged NPs, such as the strong basic (NH2) 
functionalized NPs. Opsonization is the process by which a foreign organism or particle 
becomes covered with opsonin proteins, thereby making it more visible to phagocytic cells. A 
correlation between surface charge and opsonization was demonstrated in vitro, showing 
neutral NPs have a much slower opsonization rate than charged NPs(Owens and Peppas 2006).  
The surface charge also affects protein functions. Native protein conformations are controlled 
by the shape complementarity of the hydrophobic residues that allow close packing of the cores. 
When proteins interact with NPs, the native structure is distorted, as repulsive electrostatic 
forces are counterbalanced by a large entropy loss. Hence, proteins function are disrupted 
because of the interaction(Lynch and Dawson 2008). 
Nanoparticles Size 
Generally, the highly curved NPs surface discourage the adsorption. Lundqvist used 
polystyrene NPs with different sizes (50nm and 100nm) and the lower curved NPs were able 
to adsorb more proteins than higher curved NPs(Lundqvist, Stigler et al. 2008). Lynch used 
isothermal titration calorimetry (ITC) to determine the thermodynamics of the binding of HSA 
to NPs of 50:50 N-iso-propylacrylamide/N-tert-butylacrylamide (NIPAM/BAM) with a size 
range of 70nm-700nm,(Lindman, Lynch et al. 2007). They found that the smaller the NPs are, 
(larger surface areas at the same weight-per-volume concentration), the more protein they 
adsorb(Cedervall, Lynch et al. 2007). Conclusively, the NPs size has an important role on the 
amount of proteins adsorbed on NPs.  
1.6 Aims of the project 
 
As introduced above, protein-gold nanoparticles conjugates are widely employed in various 
applications, such as biosensors, drug delivery and gene delivery. Although conjugates are 
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fundamental elements for biosensors and delivery systems, the adsorption mechanism of 
proteins onto gold nanoparticles (GNPs) has been investigated only to limited extent. The main 
aims of this project are: 1. to understand the interactions between proteins and gold 
nanoparticles and 2. to engineer proteins that efficiently bind to gold surfaces in an expected 
orientation. 
The primary aim was to investigate the role that electrostatic forces and thiol groups play in 
the adsorption mechanism of proteins to gold nanoparticles. To do this, Glutathione-S-
Transferase (GST) was used as a model protein. For the study of electrostatic forces, GST was 
adsorbed onto GNPs under different pH values, and hence different surface charges. For 
understanding the role of thiol groups, cysteines of GST were chemically blocked by N-
ethylmaleimide (NEM). The affinity and kinetics of GST and NEM-GST adsorption to gold 
nanoparticles were compared.  
The second aim was to investigate whether GST and Bovine Serum Albumin (BSA), which 
are both able to stably bind gold, could be used as an interface for further proteins conjugation 
to GNPs. This was done by verifying whether the functions of self-assembling proteins was 
preserved upon modification with either interface (GST or BSA). The work focused on two 
convenient protein-protein conjugation systems: SpyCatcher and SNAREs. These were 
recombinantely fused to GST or chemically cross-linked to BSA and adsorbed to gold 
nanoparticles. The aim was to verify whether the self-assembling proteins were able to pair 
with their partner proteins in solution. Also, SNARE-BSA conjugates were used to attempt 
self-assembly of  GNPs dimers. The project overall found that both GST and BSA are suitable 
interfaces for conjugation to gold, especially due to the availability of thiol groups. SpyCatcher 
and SNAREs conjugation systems are both able to work in combination to GNPs when either 
GST or BSA are used as an interface.     
 
Figure 1. 13: Schematic of the modular assembly of proteins onto gold nanoparticles. 
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This project provides a promising tool for modular assembly of proteins to nanomaterials. 
Figure 1.13 shows how self-assembling proteins could be used for conjugation to GNPs. The 
interface binding tested were GST and BSA. The capture protein was either a recombinant 
fusion of SNAREs or SpyCatcher to GST or a SNARE chemically crosslinked to BSA. The 
affinity tag was either a SNARE or SpyTag. Interestingly, this modular approach is not limited 
to GNPs, but to adapt to different nanomaterials, the interface binding could be possibly 
changed and investigated separately. For further applications, the affinity tag could be 
synthesized or bound with target molecules, such as antibodies, DNA and enzymes, which 
would capture the analytes in testing samples. The establishment of this modular platform for 
protein-nanoparticle conjugation was the main achievement of this project and the work will 
be discussed in detail in the next sections.   
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Chapter 2. Methods 
 
The following flow chart lists the connections between proteins and GNPs, and purposes of 
methods. 
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2.1 Synthesis and Characterization of Gold Nanoparticles 
 
2.1.1 Synthesis of GNPs by sodium citrate method 
 
Gold nanoparticles were synthesized using the well-known sodium citrate method(Turkevich, 
Stevenson et al. 1951). Briefly, all glassware which was used for the synthesis was immersed 
overnight in aqua regia (nitric acid and hydrochloric acid in a ratio 1:3), washed thoroughly 
with Milli-Q water and dried in oven. 0.125mL 2% HAuCl4 in 24.375mLMilli-Q water were 
heated on a hot plate set at 300°C while stirring at 150rpm using a magnet. When the mixture 
was boiling thoroughly, 1% sodium citrate was added rapidly, under constant stirring. The 
expected size of gold nanoparticles is determined by the volume of sodium citrate used. We 
synthesized two sets of GNPs, 15nm and 30nm, by adding 1% sodium citrate volumes of 
0.58mL and 0.4mL respectively. The colour of solution changed from transparent to dark blue. 
The solution was left boiling for about 10 extra minutes until the colour suddenly changed from 
dark blue to wine-red. Heating and stirring was kept constant for 5 extra minutes, then the 
heating was turned off, while keeping the stirring on until the solution reached room 
temperature. The gold nanoparticle suspension was stored in a very clean plastic tube at room 
temperature in dark. 
In order to compare the quality of GNPs synthesized by sodium citrate in the lab with 
commercial GNPs products, a batch of 40nm GNPs at a concentration of 5OD was bought from 
BBI Solutions.  
2.1.2 Characterization of GNPs by atomic force microscopy 
 
GNPs sample preparation for Atomic Force Microscopy (AFM) was based on a US National 
Institute of Standards and Technology (NIST) protocol(Grobelny, DelRio et al. 2011). A layer 
of mica, supported on a regular microscope glass slide, was removed by a sticky tape. This step 
was repeated many times until the exposed surface was smooth. 30μL of 0.01% poly-L-Lysine 
(PLL), providing a positively charged surface, was dropped on the flat mica substrate and 
incubated for 30min at room temperature. The PLL solution on mica was blown away using 
compressed air. 30μL of GNPs solution was applied onto the positively charged mica surface 
for 5 min at room temperature and finally dried with compress air. 
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The three sets of GNPs (15nm and 30nm GNPs from lab synthesis and 40nm GNPs from BBI 
Solutions) were prepared in the above way for AFM observation with a Bruker, Catalyst 
Bioscope.  
The images were taken using Peak Force tapping mode and ScanAsyst Air probes (Bruker) at 
room temperature. The images were recorded at the scan rate of 1 Hz, 256 lines and scan size 
of 1µm. 
2.1.3 Characterization of GNPs by nanoparticle tracking analysis 
 
Nanoparticle Tracking Analysis (NTA) was performed using Malvern Nanosight LM14. The 
three samples of GNPs described above were diluted 1:500 with Milli-Q in a volume of 
approximately 400μL to match the ideal number of particles/frame in the camera. This 
concentration corresponds to a number between 105 and 1010 particles/mL(Filipe, Hawe et al. 
2010). Data were acquired using a 1 minute video recording at room temperature. 
2.1.4 Characterization of GNPs by dynamic light scattering 
 
The hydrodynamic diameter of GNPs was determined by Dynamic Light Scattering (DLS, 
Malvern Zetasizer Nanoseries). The three sets of GNPs (15nm, 30nm and 40nm) were diluted 
5 times with filtered Milli-Q water. 1mL GNPs samples were added to disposable cuvettes 
(Polystyrol cuvette, Sarstedt). Then the cuvettes were covered with lids which were used to 
keep the samples at the set temperature of 20ºC. 
The instrument was set at 173° scattering angle. First, the instrument was equilibrated for 2 
minutes. Then 3 readings of hydrodynamic diameter (z-average) were acquired with 16 sub 
runs each.  
2.1.5 Characterization of GNPs by ultraviolet-visible spectroscopy 
 
The GNPs samples were analysed by Ultra-Violet-visible spectroscopy (UV-vis) using a 
Shimadzu UV spectrophotometer, UV-1800. Samples were prepared in semi-micro disposable 
cuvettes (Sigma) with 1mL GNPs solution. All the UV-vis spectra were scanned from 400nm 
to 700nm. A graph of optical density (OD) versus wavelength was plotted and the wavelength 
(λ) and absorbance (A) of the Surface Plasmon Resonance (SPR) peak were determined. 
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Based on published work (Haiss, Thanh et al. 2007), equation 2.1 gives a precise determination 
of diameters of GNPs ranging from 25nm to 120nm, while equation 2.2 provides a good way 
to calculate the size of GNPs between 5nm and 50nm.  
d =
In(λ−λ0 L1)⁄
L2
  
The calculation of Equation 2.1 is based on the wavelength (λ) of the peak absorbance and  λ0, 
L1 and L2 are empirical parameters with values of 512nm, 6.53 and 0.0216 respectively, which 
have been given previously (Haiss, Thanh et al. 2007).   
d⁡ = ⁡ (⁡
A(5.89×10−6)
CAuexp⁡(C1)
)
1 C2⁄
 
Equation 2.2 is calculated from the absorbance (A) at the SPR peak, CAu (in moles per litre), 
which is the initial concentration of HAuCl4·3H2O used to synthesize the GNPs (in this 
experiment was 2.42×10-4 M), C1= - 4.7 and C2=0.30 are empirical parameters that have been 
given previously (Haiss, Thanh et al. 2007).  
2.2 Protein Biochemistry  
 
2.2.1 Recombinant protein synthesis and purification 
 
All recombinant proteins were encoded in pGEX-KG vectors as Glutathione-S-Transferase 
(GST) C-terminal fusions, with a thrombin-cleavable site at the N-terminal. 
Mouse SNAP25 (synaptosomal-associated protein of 25 kDa, from NCBI Reference Sequence: 
NP_035558.1) has 4 cysteines residues in the loop that links the two SNARE domains. In this 
project three cysteines were mutated into alanine leaving the only one cysteine for the 
conjugation of a single fluorophore. The plasmid for the newly designed SNAP25, named 
SNAP25C1 was made by introducing a codon optimized (EMBOSS Backtranseq, available at 
www.ebi.ac.uk), chemically synthesized (Dundee Cell Products Ltd, UK) DNA insert into the 
EcoRI restriction site of the vector. The resulting amino acid sequence after GST tag removal 
by thrombin-cleavage was designed and shown in Table 2.1. 
 
 
(Equation 2.1) 
(Equation 2.2) 
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Sequence 
SNAP25C1 
gspgisgggggilMAEDADMRNELEEMQRRADQLADESL 
ESTRRMLQLVEESKDAGIRTLVMLDEQGEQLERIEEGMDQINKDMKEAEKNLTDLGKFCGL
AVAPANKLKSSDAYKKAWGNNQDGVVASQPARVVDEREQMAISGGFIRRVTNDARENEMDE
NLEQVSGIIGNLRHMALDMGNEIDTQNRQIDRIMEKADSNKTRIDEANQRATKMLGSGef 
SynaptobrevinC1 
gspgNLTSNRRLQQTQAQVDEVVDIMRVNVDKVLERDQKLSELDDRA 
DALQAGASQFETSAAKLGSC 
SyntaxinC1 
gspgisgggggildsmgrpIETRHSEIIKLENSIRELHDMFMDMAMLVES 
QGEMIDRIEYNVEHAVDYVERAVSDTKKAGSC 
Nanolock 
gsEGRHKDIVRLESSIKELHDMFMDIAMLVENQGEMLDNIELNVMHTVDHVEKARDEAKRA
GILDSMGRLELKLMSATAATVPPAAPAGEGGPPAPPPNLTSNRRLQQTQAQVDEVVDIMRV
NVDKVLERDQKLSELDDRADALQAGASQFETSAAKL  
Table 2. 1 SNARE proteins sequences. Amino acids in small are from the vector, and the upper case amino acids are from 
proteins sequences.  In the SNAP25C1 sequence, alanines in red are mutated from cysteines in the original mouse 
sequence. The GSC added to the C-terminal of SynaptobrevinC1 and SyntaxinC1 are highlighted in yellow. 
A second version of the protein with all cysteines mutated into alanines, named SNAP25, was 
encoded in an already available pGEX-KG derivative which has been already extensively 
described(Poirier, Hao et al. 1998) and was used as a control throughout the project.  
For conjugation to BSA and successive absorption on GNPs, the C-terminal of both 
Synaptobrevin and Syntaxin was modified with one extra cysteine and the resulting proteins 
named SynaptobrevinC1 and SyntaxinC1 respectively. The cysteine was designed to be 
separated from the SNARE domain by a glycine and serine, forming a 3 amino acids GSC short 
sequence. SynaptobrevinC1 was derived from rat Synaptobrevin2 sequence (aminoacids 25-
84) and SyntaxinC1 from rat Syntaxin 1A (aminoacids 195-254). Both DNA inserts were 
amplified from existing plasmids using the primers in Table 2.2. The amplified products were 
double digested with the restriction enzymes also shown on Table 2.2 and ligated into pGEX-
KG cut with the same enzymes. Two plasmids encoding the same proteins, but without the 
nucleotides for the GSC end, were cloned the same way for control purpose and named 
Syntaxin and Synaptobrevin.  
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Primers 
Restriction 
Enzyme 
SynaptobrevinC1 
Synaptobrevin_Forward:GGATCCC
CGGGCAATCTTACCAGTAACA
GG 
SmaI 
Synaptobrevin_Reverse:GAGTCTA
GATTAGCAGCTGCCGAGCTTG
GCTGCAC 
XbaI 
SyntaxinC1 
SYX_Forward:CATGGGTCGACC
GATCGAGACCAGGCACAG 
SalI 
SYX_Reverse:CTTGAGCTCTAGC
AGCTGCCGGCCTTCTTGGTGTC 
SacI 
Table 2. 2 Primers and restriction enzymes for SNARE proteins. The restriction sites are underlined. The sequence 
encoding the GSC is highlighted in yellow. 
The resulting sequence of thrombin-cleaved SynaptobrevinC1 and SyntaxinC1 are shown in 
Table 2.1. 
In order to make the naturally ternary SNARE complex into a  binary group, Synaptobrevin 
and Syntaxin were fused into one protein and named Nanolock. This plasmid was kindly 
donated by the Medical Research Council and it has been previously reported(Ferrari, Darios 
et al. 2010). Briefly, Nanolock protein was made by combining rat syntaxin3 (amino acids 195-
253) to rat synaptobrevin2 (amino acids 1-84), encoded in pGEX-KG vector. The thrombin-
cleaved amino acid sequences of Nanolock is shown in Table 2.1. 
The SpyCatcher protein sequence used in (Zakeri, Fierer et al. 2012) was reverse translated by 
‘Sequence Manipulation Suite’ (http://www.bioinformatics.org/sms2/rev_trans.html) for 
chemical synthesis, outsourced and provided cloned in pBluescript. The software also 
optimised the codon usage for expression in E.coli. The 5’ end of the resulting DNA sequence 
was modified with TGATCA which is the BclI restriction sites. The sequence 
GGATCCTAGGAGCTC, containing the stop codon TAG and restriction sites for BamHI 
(GGATCC) and SacI (GAGCTC) was added to the 3’ end of the DNA sequence to make a 
synthetic DNA insert for subcloning from pBluescript into pGEX-KG (Table 2.3). BamHI and 
SacI near the 3’ end of the insert were included to facilitate the subsequent insertion of a second 
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fragment designed the same way. This strategy was designed for future need of fusing several 
building blocks placed in tandem, as it would be suitable to originate a protein the type  
gsPROTEIN1gsPROTEIN2gsPROTEIN3gs (where gs is from the pGEX-KG vector). The 
DNA insert encoding SpyCatcher was synthesized (Dundee Cell Products Ltd, UK) and cloned 
in the form of un-methylated pBluescript vector. The pGEX-KG plasmid (expression vector) 
was cut by BamHI and SacI. The pBluescript plasmid (origin vector) was cut by BclI and SacI 
to obtain the insert DNA with sticky end which was ligated with the opened pGEX-KG (Table 
2.3) using T4 ligase.   
Expression pGEX-KG vector: BamHI/SacI cut 
GGATCC……GAGCTC 
CCTAGG……CTCGAG 
Origin pBluescript vector: BclI/SacI cut 
TGATCA………GGATCCTAGGAGCTC 
ACTAGT………CCTAGGATCCTCGAG 
Table 2.3 Cloning strategy for SpyCatcher. The overhangs from vectors and insert cuts are highlighted in yellow. The 
extra BamHI (red) site just before stop codon TAG converts the vector in a new potential acceptor of an insert with same 
design. The dots represent the actual insert. 
The theoretical thrombin-cleaved amino acidic sequence of SpyCatcher resulting from this 
cloning strategy is shown in Table 2.4.is the following: 
  
Sequence 
SpyCatcher 
gsGAMVDTLSGLSSEQGQSGDMTIEEDSATHIKFSKRDEDG 
KELAGATMELRDSSGKTISTWISDGQVKDFYLYPGKYTF 
VETAAPDGYEVATAITFTVNEQGQVTVNGKATKGDgs  
GST-SpyTag 
mspilgywkikglvqptrllleyleekyeehlyerdegdkwrnkkfe 
lglefpnlpyyidgdvkltqsmaiiryiadkhnmlggcpkeraeismlegavldirygvsriayskdf
etlkvdflsklpemlkmfedrlchktylngdhvthpdfmlydaldvvlymdpmcldafpklvcfkkri
eaipqidkylksskyiawplqgwqatfgggdhppksdlvprgsAHIVMVDAYKPTKgs  
Table 2. 4 Protein sequences of SpyCatcher and GST-SpyTag. The Amino acids in small are from the vector whereas the 
upper case amino acids are from proteins sequences 
The DNA insert of SpyTag was designed for the same cloning strategy, but given the short 
length, it was simply obtained by two annealed complementary oligos which contain sticky 
ends for the subsequent subcloning into pGEX-KG. The target amino acid sequence of SpyTag 
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(AHIVMVDAYKPTK)(Zakeri, Fierer et al. 2012) was reversed translated by ‘Sequence 
Manipulation Suite’ (http://www.bioinformatics.org/sms2/rev_trans.html). The software also 
optimised the codon usage for expression in E.coli. The reverse translated sequence of SpyTag 
amino acid was named oligo1. Oligo2 was designed as the reverse-complementary sequence 
of oligo1, obtained using Bio-Web resources 
(http://www.cellbiol.com/scripts/complement/dna_sequence_reverse_complement.php). The 
leading sequence GATCA and the end sequence GGATCCTAGGAGCT were added to oligo1. A 
stop codon TAG was added just after the introduced BamHI (GGATCC) of oligo1. For oligo2, 
the leading sequence CCTAGGATCC and an end nucleotide T were added to match the sticky 
ends of the destination vector. The end codons of oligo1 and oligo2 were designed for the 
ligation into the pGEX-KG vector (Table 2.5).  
Expression pGEX-KG vector: BamH1/Sac1 cut 
GGATCC……GAGCTC 
CCTAGG……CTCGAG 
Annealed complementary oligos 
5' GATCA……GGATCCTAGGAGCT 3' 
3' T……CCTAGGATCC 5' 
 
Table 2.5 Schematic of the cloning strategy of SpyTag. The pGEX-KG vector was cut by BamHI and SacI, where the 
sticky end of oligos were located (highlighted in yellow). The dots represent the DNA insert of SpyTag. The annealed 
oilgos was introduced with a BamHI site (red) before the stop codon TAG. 
The pGEX-KG vector was cut by BamHI (GGATCC) and SacI (GAGCTC), and then the removed 
sequence of vector was ligated with the annealed complementary oligos (Sigma).  
SpyTag was kept as a fusion to the GST affinity tag after affinity purification. The theoretical 
protein sequence of GST-SpyTag is shown in Table 2.4.  
Cloning of all the plasmids was made using XL1 Blue E. coli rubidium chloride competent 
cells (Agilent). Clones presenting the expected inserts and orientation were Sanger sequenced 
in two directions using pGEX5 and pGEX3 primers to confirm the sequences before 
proceeding to expression and purification. 
All the proteins were expressed in E.coli, bacterial strain BL21-gold (DE3) pLysS competent 
cell (Agilent). 30µL of competent cells were transformed with 1µL of vector. 300µL of Super 
Optimal Broth (SOB) medium (pre-warmed at 37℃) was added to the transformed cells and 
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incubated in a shaker for 1 hour at 37℃. The transformants were spread on Luria-Bertani (LB) 
plates containing ampicillin (100µg/mL) and chloramphenicol (30µg/mL) and incubated at     
37℃ overnight. 5mL of 2xTY (Tryptone, Yeast extract) medium containing ampicillin 
(50µg/mL) and chloramphenicol (50µg/mL) were inoculated with a colony picked from the 
plates. The culture was incubated at 37℃ overnight in a shaker. The overnight culture was 
diluted into 0.5L of 2xTY medium containing ampicillin (50µg/mL) and chloramphenicol 
(50µg/mL) in a 2L conical flask and grown at 37℃ in a shaker until the OD (optical density) 
value at 600nm  culture reached 0.5-0.7. 100µM IPTG (Isopropyl β-D-1-thiogalactopyranoside, 
Melford) was added to induce protein expression and the culture was incubated at 18℃ in a 
shaker overnight.  
Bacteria were harvested by transferring the culture into 0.5L polycarbonate bottles. The 
cultures were centrifuged at 3000g for 20min using a JLA 10.500 rotor in a J25 centrifuge 
(Beckman, Avanti J-26s XP). The pellet was suspended using 10mL Lysis Buffer (20mM 
HEPES pH 7.4, 500mM NaCl and 1mM EDTA). All the lysates were collected and transferred 
into a 50mL Falcon tube. 300µL of a 1ml solution containing a dissolved tablet of Complete 
Protease Inhibitor Cocktail (Roche) was added to the lysate to prevent protease degradation. In 
order to break the cell walls, the lysate was instant-frozen in liquid nitrogen for 10min, and 
thawed at 42℃ for 30min. 1mM of MgCl2 and 400µL of 1mg/mL deoxyribonuclease I (from 
bovine pancreas, ≥400 Kunitz unit/mg Sigma) was added to Falcon tube and rotated at room 
temperature for 10min to digest DNA and reduce the viscosity of the lysate. 2% TritonX-100 
detergent was added to the lysate and incubated for 20min at 4℃. The lysate was transferred 
into a centrifuge tube and spun down at 10000g for 20min at 4℃ using a JA-25.50 rotor in a 
J25 centrifuge (Beckman, Avanti J-26s XP). 
The GST-fusion proteins were affinity-purified using glutathione resin. The supernatant was 
mixed with glutathione-sepharose beads under gentle rotation at 4℃ for 1.5 hours. The beads 
were washed twice using High Salt Buffer (20mM HEPES, 1M NaCl, 1mM EDTA, 0.1% 
TritonX-100), followed by two washes using Low Salt Buffer (20mM HEPES, 100mM NaCl, 
1mM EDTA, 0.1% TritonX-100). In order to elute the affinity purified proteins from the 
glutathione resin, the beads were transferred into a 2mL eppendorf tube, washed with Buffer A 
(containing 20mM HEPES and 100mM NaCl, pH7.4), the volume adjusted to 1.5mL. The GST 
affinity tag was cleaved by incubating with 16.7U of thrombin (from bovine plasma, Sigma) 
for 1 hour at room temperature, shaking at 1000rpm. The eluate was separated from the beads 
using spin columns (Generon) and 30µL of Complete Protease Inhibitor Cocktail (from the 
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same stock used during bacterial lysis) was added to stop thrombin activity. 
For some of the proteins (GST, GST-SNAP25, GST-SpyCatcher and GST-SpyTag) which were 
kept as GST C-terminal fusions, the beads were eluted with 5ml gluthathione (GSH) buffer 
(15mM Glutathione H, 250mM NaCl, 20mM HEPES, pH8.5) at 4°C for 30 minutes with 
3000rpm shaking. The beads were spin down at 3000g for 1 minute. The first eluate was saved 
in a Falcon tube. 1ml GSH elution buffer was added to beads for another 15 minutes incubation 
at 4°C for with 3000rpm shaking. Then the beads were separated by centrifugation at 3000g 
for 1 minute. The second eluate was saved in an Eppendorf tube. The first and second elute 
were mixed before concentrating.  
The combined eluates were concentrated to about 0.55ml using a Vivaspin 2 concentration 
column (Satorius), MWCO (Molecular Weight Cut-Off) of 10kDa for further purification by 
size exclusion chromatography.  
The concentrated eluate was injected into an Akta FPLC (Fast Protein Liquid Chromatography) 
device (GE Healthcare) equipped with a Superdex 200 10/200 GL column (GE Healthcare). 
The collected fractions presenting high absorbance at 280nm were examined by Instantblue 
(Expedeon Company) stained SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and 
pulled-together for conservation at -80ºC. The concentration of the resulting purified proteins 
was measured using BCA (bicinchoninic acid, protein assay, Thermo Scientific Pierce) kit.  
2.2.2 Protein functional assays 
 
SNAREs functionality was assessed by formation of a SNARE complex by simple mixing of 
5μM of SNAP25C1, SynaptobrevinC1 and SyntaxinC1 or 5μM of SNAP25 and Nanolock in 
Buffer A with 0.8% OG (n-Octyl-β-D-glucoside, Sigma). The assembly was performed at room 
temperature for 1 hour and in a volume of 10μL. SNARE complex is unusually strong and 
cannot be denatured in SDS, therefore its assembly was assessed simply by using SDS-PAGE. 
However, heating a mixture containing SNARE complex in presence of SDS does break the 
quaternary structure. Therefore, 10µL complex solution was equally aliquoted into two tubes, 
5µL of 2X SDS gel loading buffer was added to each tube and only one of the tubes was heated 
at 100°C for 2 minutes. The heated and non-heated complex samples were run in 12% 
acrylamide SDS-PAGE in cold buffer, representative of the individual components and 
complex respectively. The cold buffer was necessary to prevent partial disassembly of the 
SNARE complex due to the heating from the electrophoresis apparatus. The complex formation 
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was assessed from the appearance of high molecular weight compounds that were absent in the 
heated samples. 
The formation of a SpyCatcher/GST-SpyTag complex formed thorough isopeptide bond was 
assessed by mixing 5μM of SpyCatcher and GST-SpyTag. The isopeptide bonds are covalent 
bonds that cannot be dissociated in SDS-PAGE. Hence, 5µL of 2X SDS gel loading buffer was 
added to 5µL SpyCatcher/GST-SpyTag and the mixture was heated at 100°C for 5 minutes. 
The heated sample was run in 12 % precast SDS-PAGE (RunBlue SDS Protein Gels, expedeon) 
to verify conjugation by change of the molecular weight. 
 
2.2.3 Chemical modification of proteins 
 
Thiol reduction of single-cysteine SNARE proteins 
The single-cysteine SNARE proteins, SNAP25C1, SynaptobrevinC1 and SyntaxinC1, were 
reduced by Tris-(2-crboxethyl) Phosphine (TCEP) to break disulphide bonds. For the purpose 
of finding the best conditions for the reduction, the concentration of TCEP and incubation time 
were optimized. SNAP25C1 was used for optimization. Different concentrations of TCEP 
(0mM, 0.1mM, 0.5mM and 1mM) were added to 50µM SNAP25C1and incubated at 4ºC 
overnight. Then the solution was spun in a Zeba Spin Desalting Columns, 7K MWCO (Thermo 
Scientific) to remove TCEP. 5μL of 2X SDS gel loading buffer (without β-mercaptoethanol) 
was mixed with 5μL reduced SNAP25C1. β-mercaptoethanol is a weaker reductant of 
disulphide bonds than TCEP, however it is still able to reduce SNAP25C1, therefore, in order 
to check the reduction efficiency of TCEP, SDS gel loading buffer without β-mercaptoethanol 
was employed. The reduced SNAP25C1 was run on 12% SDS-PAGE. 50µM SNAP25C1 was 
reduced by 1mM TCEP for overnight, 8 hours, 5 hours, 3 hours, 1 hours and 0 hour separately. 
TCEP was removed by Zeba Spin Desalting Columns, 7K MWCO (Thermo Scientific). 
Reduced SNAP25C1 was mixed with 2X SDS gel loading buffer (without β-mercaptoethanol) 
for the SDS-PAGE analysis. In all the following experiments, the single-cysteine SNARE 
proteins were reduced by 1mM TCEP overnight before use, as this were the conditions that 
gave the best reduction in the optimization. 
Cy3-maleimide conjugation to SNAP25C1 
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The cysteine of SNAP25C1 was labeled with Cy3-maleimide. 0.5g Cy3-maleimide (GE 
Healthcare) was dissolved in 50µL dimethylformamide (DMF) anhydrous for storage. 5μL 
Cy3-maleimide solution and 0.1mg reduced SNAP25C1 were gently mixed and incubated at 
room temperature for two hours with additional mixing every 20 minutes. Further incubation 
was performed at 4℃ overnight. Finally, the labeled SNAP25C1 was separated from the excess 
of Cy3-maleimide using Zeba Spin Desalting Columns, 7K MWCO. The SNAP25C1-Cy3 
conjugate was run in the SDS-PAGE gel to verify molecular weight and fluorescence. 
SNAP25C1-Cy3, SynaptobrevinC1 and SyntaxinC1 were mixed and incubated at room 
temperature for 1 hour in the presence of 0.8% OG to verify the functionality of the modified 
SNAP25. 10µL of 2X SDS gel buffer were added to 10µL single-cysteine SNARE proteins 
complex. Half amount of this mixture was boiled at 100°C for 2 minutes. The boiled and non-
boiled complex samples were run in 12% SDS-PAGE in cold buffer. 
Optimization of SNARE-BSA conjugation 
SynaptobrevinC1 and SyntaxinC1 were designed to combine with BSA through 
Sulfosuccininidyl 4-[N-maleimidomethyl] cyclohexane-1-carboxylate (Sulfo-SMCC, Figure 
2.1). Sulfo-SMCC is a water soluble heterobifunctional crosslinker which could combine 
amine- and sulfhydryl- through N-hydroxysuccinimide (NHS) ester and maleimide. For a long 
time storage, 20mM Sulfo-SMCC was dissolved in dimethyl sulfoxide (DMSO) and kept at     
-20°C.  
 
Figure 2.1  The chemical structure of Sulfo-SMCC, the NHS ester group (blue) links to amino groups, while the 
maleimide group (green) links to sulfhydryl groups. 
The cysteine of SynaptobrevinC1 or SyntaxinC1 were expected to combine with maleimide, 
and then BSA was expected to combine with activated SynaptobrevinC1 or SyntaxinC1 by the 
action between amines and NHS ester. In order to combine SNARE protein and BSA in the 
expected orientation, SynaptobrevinC1 or SyntaxinC1 were incubated with Sulfo-SMCC first, 
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then BSA was added to the activated SNARE. The scheme of the combination is shown in 
Figure 2.2. Both SynaptobrevinC1 and SyntaxinC1 were linked to BSA in the same way, 
therefore, SyntaxinC1 was used as an example for optimization. 
 
Figure 2.2 Schematics of crosslinking reaction. SNARE proteins were linked to maleimide firstly and then BSA was 
combined with NHS-ester. 
To ensure the free cysteine of SyntaxinC1 would not be oxidized during maleimide reaction, 
TCEP was kept in the maleimide step of the conjugation reaction. This was also because Zeba 
Spin Desalting Columns (Thermo Scientific) do not have 100% recovery, therefore removal of 
TCEP at this stage was avoided to minimise protein loss. To verify TCEP does not compromise 
the conjugation, the maleimide reaction with or without TCEP were compared. 50µM 
SyntaxinC1 were reduced by 1mM TCEP overnight, then TCEP was removed by desalting 
columns. In another reaction, TCEP was kept after reduction. The two different treatments of 
SyntaxinC1 were incubated with 1mM Sulfo-SMCC for 1 hour at room temperature separately. 
30µM BSA were reacted with 30µM SyntaxinC1-NHS for 1 hour at room temperature. The 
conjugate was checked by 12% SDS-PAGE.  
The relative concentration of Sulfo-SMCC and BSA was then optimized. Different 
concentrations of Sulfo-SMCC (1mM, 5mM, and 10mM) were incubated with reduced 50µM 
SyntaxinC1 at room temperature for 1 hour. The excess of Sulfo-SMCC was removed by Zeba 
Spin Desalt Columns, 7K MWCO (Thermo Scientific). 30µM BSA were added to 30 µM 
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SyntaxinC1-NHS and incubated 1 hour at room temperature. The Syntaxin-BSA conjugate was 
analysed by 12% SDS-PAGE to verify the crosslinking reaction.  
50µM of reduced SyntaxinC1 and 1mM Sulfo-SMCC were mixed for 1 hour incubation at 
room temperature. Excess Sulfo-SMCC was removed by Zeba Spin Desalting Columns, 7K 
MWCO (Thermo Scientific). 10µM, 30µM and 40µM BSA were added to 30µM SyntaxinC1-
SMCC separately for 1 hour incubation. 12% SDS-PAGE gel was employed to verify the 
conjugate.   
The crosslinking reaction has two steps. First, Sulfo-SMCC was reacted with SyntaxinC1, then 
BSA was linked to the activated SyntaxinC1. The incubation time of the two reactions was 
optimized to achieve highest efficiency and prevent over-crosslinking.  
50µM of reduced SyntaxinC1 was reacted with 1mM Sulfo-SMCC at room temperature for 
overnight, 5 hours, 1 hour and 0.5 hour separately. Zeba Spin Desalt Columns (7K MWCO, 
Thermo Scientific) was used to remove excess Sulfo-SMCC. 30µM BSA was added to 30µM 
activated SyntaxinC1 for 1 hour incubation at room temperature. 10μL 1X SDS gel loading 
buffer was mixed with 2μL conjugate. This conjugate was checked in 12% SDS-PAGE gel to 
find the best incubation time. 
For the BSA reaction, 50µM of reduced SyntaxinC1 was mixed with 1mM Sulfo-SMCC for 1 
hour incubation at room temperature. Excess Sulfo-SMCC was removed by Zeba Spin Desalt 
Columns (7K MWCO, Thermo Scientific). 30µM BSA were added to 30µM SyntaxinC1-NHS 
for overnight, 5 hours, 1 hour and 0.5 hour incubation at room temperature and analysed by 
SDS-PAGE. 
Orientation of SNARE-BSA conjugates 
In order to check whether conjugates of SyntaxinC1-BSA and SynaptobrevinC1-BSA were 
linked in the expected orientation, 50 µM of Synaptobrevin, SynaptobrevinC1, Syntaxin and 
SyntaxinC1 were mixed with 1mM Sulfo-SMCC separately for 1 hour incubation at room 
temperature. The excess Sulfo-SMCC was removed by Zeba desalting columns. 30 µM of 
Synaptobrevin-SMCC, SynaptobrevinC1-SMCC, Syntaxin-SMCC and SyntaxinC1-SMCC 
were added to 30 µM BSA separately. The incubation lasted for 0.5 hour at room temperature. 
The results were verified by 12% SDS-PAGE.  
SNARE complex formation by SNARE-BSA conjugates 
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SNARE-BSA conjugates and SNAP25C1-Cy3 were mixed to form SNARE complex. 5µM 
conjugated SyntaxinC1-BSA and SynaptobrevinC1-BSA were mixed with 5µM SNAP25C1-
Cy3 and incubated at room temperature for 1 hour. 10µL complex solution was equally 
aliquoted into two tubes, 5µL of 2X SDS gel loading buffer was added to each tube and only 
one of the tubes was heated at 100°C for 2 minutes. The samples were run in 12% SDS-PAGE 
in cold running buffer. 
All the SDS-PAGE gels were stained by Instant Blue (Expedeon) for 30 minutes, then distained 
by water for 10 minutes. The gels were analysed by ChemiDoc MP (BioRad). 
2.2.4 Estimation of protein concentration  
 
Apart from the fluorescent SNAP25C1-Cy3, the concentration of the other proteins was 
measured by BCA (Bicinchoninic acid) kit (Thermo Scientific) according to the manufacturer 
protocol.  
Briefly, BSA standards were prepared by diluting 2mg/ml BSA stock (provided in the BCA 
kit) with filtered Milli-Q water (Table 2.6). Working reagent was prepared by mixing 50 parts 
of BCA Reagent A with 1 part of BCA Reagent B.  
Vial 
Filtered Milli-Q water 
(µL) 
Volume and Source of BSA (µL) 
Final BSA Concentration 
(µg/mL) 
A 0 300 of stock 2000 
B 125 375 of stock 1500 
C 325 325 of stock 1000 
D 175 175 of vial B dilution 750 
E 325 325 of vial C dilution 500 
F 325 325 of vial E dilution 250 
G 325 325 of vial F dilution 125 
H 400 100 of vial G dilution 25 
I 400 0 0=Blank 
Table 2. 6 Preparation of BSA standards 
25µL of each BSA standard or protein samples were pipetted into a 96 well microplate. 200µL 
working regent were added to each well and mixed with proteins thoroughly by pipetting. 
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Under this conditions, the working measurement range is 20-2000µg/mL according to the 
manufacturer of the BCA kit. The plate was covered with a lid, and then incubated at 37°C for 
30 minutes. The plate was allowed to cool down to room temperature. The absorbance of 
proteins was measured at 562nm on a plate reader (TECAN infinite M200 Pro).   
The concentration measurement of SNAP25C1-Cy3 was not carried out by BCA assay, as Cy3 
has the maximum absorbance at 552nm which could affect the absorbance of BCA 
measurement at 562nm. SNAP25C1 has a very little difference of molecular weight compared 
to SNAP25C1-Cy3, therefore the gel filtration could not separate those two molecules, the 
concentration of true SNAP25C1-Cy3 was estimated by measuring the concentration of Cy3, 
based on its absorbance and extinction coefficient. Molar concentration of Cy3 and SNAP25C1 
were calculated by Equation2.3 and Equation2.4 respectively (based on the maleimide-Cy3 
protocol from GE Healthcare). The Equation2.5 is the molar concentration ratio which 
indicates the number of Cy3 combined to SNAP25C1 and the efficiency of the maleimide-thiol 
reaction.                                                                 
[Cy3] = (A552)/150 000   (Equation 2.3) 
[SNAP25C1] = [A280-(0.08 • A552)]/28990   (Equation 2.4) 
C/S = [Cy3]/[SNAP25C1]   (Equation 2.5) 
A552 and A280 were the absorbance at 552nm and 280nm respectively. The absorbance was 
measured by Nanodrop (Thermo Scientific). Molar extinction coefficients of 28990M-1cm-1 at 
280nm for SNAP25C1 and 150000M-1cm-1 at 552nm for Cy3 were used in the equations. For 
the concentration of SNAP25C1, the calculation was corrected at 280 nm (approximately 0.08 
of the absorbance at 552 nm). Equation 2.3 was used to calculate the Cy3 concentration which 
equals the concentration of SNAP25C1-Cy3, as the excess Cy3 was removed during gel 
filtration and does not contribute to the overall fluorescence of the preparation. The C/S value 
estimated the reaction efficiency between maleimide and cysteine. 
2.2.5 Blocking of thiol groups by N-ethylmaleimide  
 
The thiol groups of GST and GST-SpyTag were blocked by N-Nethylmaleimide (NEM, Sigma) 
to obtain NEM-GST and NEM-GST-SpyTag respectively. NEM was equilibrated at room 
temperature before opening to prevent condensation in the bottle and subsequent hydrolysis 
and loss of function.  
45 
 
For long time storage, 100mM NEM was dissolved in DMSO. A minimum of a 10-fold molar 
excess of NEM was added to sulfhydryl groups, since each GST molecule has 4 cysteines, 
1.2mM NEM was added to 30 µM GST or GST-SpyTag. The reaction was performed at room 
temperature for 2 hours. The excess NEM was removed by Zeba Spin Desalting Columns, 7K 
MWCO. The remaining thiol groups of NEM-GST and NEM-GST-SpyTag were determined 
by Ellman's Reagent (5, 5’-Dithio-bis-(2-nitrobenzoic acid)).  
4mg Ellman’s reagent was dissolved in 1mL reaction buffer (0.1M sodium phosphate buffer: 
0.1M KH2PO4, 0.1M Na2HPO4, 1mM EDTA, pH8.0). L-Cysteine was used as standard 
solution (Table 2.7). L-Cysteine (Sigma) was dissolved in reaction buffer to make a 400µM 
stock, then diluted to 10µM, 50µM, 100µM, 150µM, 200µM, 250µM, 300µM by reaction 
buffer. The working buffer was made by mixing Ellman’s reagent and reaction buffer with the 
ratio of 1:2. 50µL L-Cysteine standards or protein samples were mixed with 150µL working 
buffer for a 10 minutes incubation at room temperature in 96 well micro plate. The absorbance 
was measured at 412 nm (TECAN infinite M200 Pro). The standard curve was based on the 
absorption of different concentration of L-Cysteine solution and the thiol concentration of 
NEM-GST and NEM-GST-SpyTag was calculated based on the equation of the standard curve.  
  400uM L-Cysteine Reaction Buffer 
400uM 500uL 0uL 
300uM 56.25uL 43.75uL 
250uM 62.5uL 37.5uL 
200uM 75uL 75uL 
150uM 30uL 30uL 
100uM 70uL 70uL 
50uM 30uL 30uL 
10uM 10uL 90uL 
0uM 0uL 100uL 
Table 2. 7 Preparation of L-Cysteine standard solution. 
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2.3 Adsorption of proteins on GNPs 
 
2.3.1 Equilibrium binding of proteins to GNPs 
 
40nm BBI GNPs were used for the equilibrium binding study. 100µL 1OD GNPs were mixed 
with 900µL buffer phosphate buffer of four different pH, prepared by mixing fixed volumes of 
0.1M KH2PO4 and 0.1M Na2HPO4 (Table 2.8) to a final concentration of 0.01M phosphate. 
The final pH of each phosphate buffer was measured by the calibrated pH meter (H12210 
Henna Instruments), the pH values were confirmed as 6.0, 6.5, 7.3 and 8.0.  
0.1M KH2PO4 (mL) 0.1M Na2HPO4 (mL) pH value 
90 10 6.0 
70 30 6.5 
20 80 7.3 
5 95 8.0 
Table 2. 8 Preparation of phosphate buffer at different pH value 
For the adsorption analysis of GST-SNAP25/SNAP25 and GST-SpyCatcher/SpyCatcher, 
100µL 1OD GNPs was added to 900µL Buffer B (10mM HEPES, 10mM NaCl, pH7.3).  
The adsorption of proteins to GNPs results in size increasing which was measured by Dynamic 
Light Scattering (DLS, Malvern Zetasizer Nanoseries). There was a 2 minutes equilibration 
time to prepare the instrument temperature reaching up to 20°C. The scattering angle was fixed 
at 173°. 3 readings of hydrodynamic diameter (z-average) were taken for each sample. The 
hydrodynamic diameter of GNPs only was measured first without addition of protein, then 
increasing volumes of 30µM proteins were added to GNPs as follows in Table 2.9.  
  GNPs 
(1OD) 
Buffer (µl) Protein volume 
to add (µl) 
Protein total 
volume (µl) 
Total volume 
(µl) 
Protein 
concentration (µM) 
A 100 900 0 0 1000 0 
B 100 900 5 5 1005 0.15 
C 100 900 5 10 1010 0.3 
D 100 900 10 20 1020 0.59 
E 100 900 10 30 1030 0.87 
F 100 900 10 40 1040 1.15 
G 100 900 15 55 1055 1.56 
H 100 900 15 70 1070 1.96 
Table 2. 9 Preparation of DLS measurement 
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The increase in diameter (∆d) was calculated by subtracting GNPs diameter at zero 
concentration. A graph of ∆d versus the protein concentration was plotted to determine the 
affinity curve. The data points were fitted by nonlinear least-squares method (Kemmer and 
Keller 2010)to an equilibrium binding curve. Finally, the equilibrium dissociation constant (KD) 
and maximum increasing diameter (∆dMAX) were calculated from Equation 1.6. The sum of the 
weighted square roots (SWSR) for these parameters were calculated and minimised by the 
solver tool of excel, and the confidence interval was assessed using the Fishers’ F-distribution 
with a confidence interval of 95%.  
 
2.3.2 Kinetic binding of GST and NEM-GST to GNPs 
 
For the kinetic binding study, the procedure of DLS was set up as follows: 90µL 1OD 40nm 
BBI GNPs were added into a micro disposable cuvette and 15 single size measurements were 
taken with 30 seconds interval between each reading. The GNPs diameter was measured 
without any protein in the first reading, then 10µL GST or NEM-GST with different final 
concentration (0.02µM, 0.05µM, 0.1µM, 0.2µM and 0.5µM) was added to the cuvette during 
the 30 seconds between first and second reading. The increasing diameter (∆d) of 15 readings 
was recorded. For different proteins concentration, the graph of ∆d (nm) versus time (s) was 
plotted. The maximum increasing diameter (∆dMAX, nm) of each concentration versus the 
relevant concentration was plotted and fitted by nonlinear least-squares data fitting procedure. 
K = Kon [M] + Koff    (Equation 2.6, [M] is the protein concentration.) 
The ∆dMAX and rate constant (K) of relevant concentrations were calculated based on Equation 
1.8, K versus concentration was plotted and the data points were fitted by linear curve. The 
association constant (Kon) and dissociation constant (Koff) were estimated by the Equation 2.6.  
2.3.3 Au-S formation determination by β-Mercaptoethanol stability assay 
 
0.4 OD 40nm GNPs (BBI Solutions) were incubated with 1.5µM GST or NEM-GST at room 
temperature for 1 hour, 30 minutes, 20 minutes, 10 minutes, 5 minutes, 2 minutes and 0 minute 
in a total volume of 200µL. Then 0.2mM β-Mercaptoethanol was incubated with the GNPs 
proteins conjugates for 20 minutes at room temperature.  
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With regards to GNPs conjugates with GST-SNAP25, SNAP25, GST-SpyCatcher and 
SpyCatcher, 0.2OD 40nm GNPs (BBI Solutions) were incubated with 1.5µM of each protein 
at room temperature for 20 minutes. 0.2mM β-Mercaptoethanol was mixed with the GNPs 
conjugates, and the incubation was last for 20 minutes at room temperature.   
The absorbance between 400nm and 700nm was measured by Surface Plasmon Resonance 
(TECAN infinite M200 Pro) with 5nm steps and the absorbance ratio between 530nm (nearest 
to the expected Surface Plasmon Resonance peak) and 600nm readings (Ab530nm/600nm) was 
used to describe the GNPs aggregation. The Ab530nm/600nm value versus incubation time was 
plotted for analysing the chemi-sorption of GST and NEM-GST to GNPs. 
2.3.4 Zeta-Potential determination of GNPs/GST at different pH values 
 
The zeta-potential of GNPs and GNPs/GST conjugates at different pH (pH6.0, 6.5, 7.3 and 8.0) 
was measured by Malvern Zetasizer. 1mL of 0.1OD 40nm GNPs (BBI Solutions) was carefully 
injected into a zeta-potential cuvette (Malvern) by a 1mL syringe paying attention not to 
introduce air bubbles. The z-potential was determined at each pH for both naked particles and 
after incubation for 20 minutes with 0.5µM GST (final concentration).  
The Zeta-Potential measurement parameters were set as follows: there was a 2 minutes 
equilibration time before the measurement, each measurement had 4 readings, each reading 
had 25 runs, 60 seconds interval was set between each reading. The average value of the zeta-
potential was calculated from 4 readings. The graphs of zeta-potential versus pH was plotted 
for both naked GNPs and GNPs/GST.  
2.3.5 Mapping of GST surface charge at different pH 
 
The calculation of surface charge of GST at different pH (6.0, 6.5, 7.3, and 8.0) was based on 
the Adaptive Poisson-Boltzmann Solver (APBS) solvation model which is an algorithm to 
solve the Poisson-Boltzmann equation and calculate the electrostatic potential of a surface.  
GST PDB (protein data bank) structure file (ID 1UA5) was used as the input and the 
distribution of potential calculated at different pH from the APBS server (University of 
California San Diego, http://nbcr-222.ucsd.edu/pdb2pqr/) was converted into a 3D plot by 
Chimera software  (University of California San Francisco, https://www.cgl.ucsf.edu/chimera/). 
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2.4 Modular assembly of proteins on GNPs  
 
2.4.1 Agarose gel electrophoresis of GNPs-protein conjugates 
 
10µL 1OD 40nm BBI GNPs were mixed with increasing concentrations (0.15, 0.30, 0.59, 0.87, 
1.15, 1.56, 1.96 µM) of GST-SNAP25 in a final volume of 20µL in Buffer B and incubated for 
1 hour at room temperature. After incubation, they were mixed with 5% glycerol, loaded in a 
0.8% agarose gel and run in 0.25xTBE (22.5mM Tris-borate, 1mM EDTA, pH8.3) for 50 
minutes at 75V. A sample of GNPs with no protein was also loaded as the negative control. 
The agarose gel was imaged by ChemiDoc MP (BioRad) to estimate the migration of the 
intensely red bands corresponding to GST-SNAP25-coated GNPs. 
In order to study the SNARE proteins assemble on GNPs, 1.5µM GST-SNAP25 were mixed 
with 1OD 40nm BBI GNPs, incubated for1 hour at room temperature, then mixed with 3µM 
Nanolock and incubated for 2 hours at room temperature. A mixture made of GNPs/GST and 
Nanolock was prepared in parallel and used as the negative control. The two groups of mixture 
with Nanolock were run in the 0.8% agarose gel (0.25×TBE buffer, 50 minutes, 75V). 
2.4.2 SDS-PAGE of GNPs-protein conjugates 
 
1OD 40nm GNPs (BBI Solutions) were incubated with 250nM GST-SNAP25 or GST (control) 
for 1 hour at room temperature. The final volume of this mixture was made up to 50µL by 
adding Buffer B (10mM HEPES and 10mM NaCl, pH7.3). 500nM Nanolock was added to 
GNPs/GST-SNAP25 or GNPs/GST (control) and incubated for 3 hours at room temperature to 
allow SNARE complex formation.  
Similarly, 500nM GST-SpyCatcher were added to 1OD 40nm GNPs (BBI Solutions), and the 
final volume was made up to 50uL by adding Buffer B, incubated at room temperature for 1 
hour. 500nM NEM-GST-SpyTag or NEM-GST (control) were added to GNPs-GST-
SpyCatcher respectively, and incubated at room temperature for 3 hours.  
All the above GNPs-protein conjugates were centrifuged at 5000g for 5 minutes after 
incubation. The GNPs pellets were resuspended in 50µL Buffer B. The centrifugation and 
suspension were repeated for three times to remove the uncomplexed proteins. 
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In order to release the proteins from the particles and allow them to migrate into the SDS-
PAGE gel, we used harsh conditions to break the Au-S covalent bond between GNPs and 
adsorbed proteins (GST). 15uL GNPs-protein conjugates were added to 5uL 4X SDS-PAGE 
loading buffer (0.06M Tris pH6.8, 10% glycerol, 2% SDS, 0.005% bromophenol blue, 5% β-
mercaptoethanol), heated at 100°C for 5 minutes, then left in 42°C water bath for 10hours. The 
proteins were fully recovered after removal of GNPs by centrifugation at 5000g for 5 minutes 
and loaded in 12% precast SDS-PAGE gel, run at 170V for 55 minutes with fresh running 
buffer. The gel was stained by InstantBlue for 6 hours, then distained by water for 10 hours on 
a shaker to display the total protein bound to GNPs samples. 
2.4.3 DLS measurement of protein complexes assembled on GNPs 
 
100µL 1OD 40nm GNPs (BBI Solutions) were diluted to 1mL by filtered Buffer B. The naked 
GNPs size was determined by DLS as described in 2.3.1. Then excess GST-SNAP25 at a 
concentration of 1.5µM was added and the size of GNPs/GST-SNAP25 measured by DLS. 
3µM Nanolock was added to GNPs/GST-SNAP25 mixture and the size was measured by DLS 
after 3 hours incubation at room temperature to assess the binding of Nanolock to GNPs/GST-
SNAP25. As the negative controls, GST was incubated with GNPs in the same condition as 
GST-SNAP25 and measured in parallel without and with the same amount of Nanolock.  
Similarly, GNPs were saturated by 1.5µM GST-SpyCatcher and the GNPs conjugate size was 
measured by DLS, then 3µM NEM-GST-SpyTag was added and the size was measured again 
after the incubation of 3 hours. NEM-GST, lacking the SpyTag, was incubated with 
GNPs/GST-SpyCatcher as negative control.  
The experiments were repeated in triplicate on independently prepared samples. All measured 
sizes were expressed as the average value of the three replicates with standard deviation.  
2.5 Assembly of gold nanoparticles dimers using SNARE-BSA conjugates 
 
6.5µM SyntaxinC1-BSA and SynaptobrevinC1-BSA were incubated with 100µL of 1OD 
40nm GNPs and 1OD 20nm GNPs respectively for 1 hour at room temperature. 
GNPs/SNARE-BSA conjugates were spun down at 5000g for 5 minutes. Then the GNPs 
conjugates were suspended in 100µL Buffer B. GNPs/SyntaxinC1-BSA and 
GNPs/SynaptobrevinC1-BSA were mixed in a 0.5mL Eppendorf tube. 6.5µM SNAP25C1-Cy3 
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was added to the mixture for a 1 hour incubation at room temperature to make GNP dimers. 
Finally, the dimers were observed by AFM as described in section 2.1.2. 
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Chapter3. Results and discussion 
 
3.1 Synthesis and characterization of gold nanoparticles 
 
This section reports the synthesis and characterization of the GNPs that were used for all the 
subsequent experiments. Two sets of GNPs were synthesized with an expected size of 15nm 
and 30nm respectively. The different size can be useful in nanoparticle assembly, for example, 
to assess specific, protein-driven dimerization of GNPs.  Commercial GNPs were also bought 
and their quality compared with lab synthesized GNPs. The sizes of all GNPs were 
characterized by AFM, NTA, UV-vis and DLS.   
3.1.1 Characterization of gold nanoparticles by AFM 
 
AFM allowed direct visualisation and high-resolution imaging of nanoparticles. AFM images 
were used to observe the shape and size of GNPs and were used to generate a distribution based 
on the height measurement of hundreds of particles from several images. The height of a 
particle on a very flat surface such as mica can be determined very accurately by AFM, while 
the diameter of the same can be affected by the limited lateral resolution of this technique. For 
this reason the diameter was expressed as height of a spherical particle rather than its lateral 
dimension.  
The AFM study (Figure 3.1A and 3.1B) shows the size of lab synthesized GNPs was 
homogeneous, and morphology was as spherical as commercial 40nm BBI Solutions GNPs 
(Figure 3.1C). According to the distribution in Figure 3.1D, 3.1E and 3.1F, most of GNPs had 
a diameter of 26.2nm, 18.8nm and 37.8nm respectively, which is close to the expected size.  
3.1.2 Characterization of Gold Nanoparticles by NTA 
 
Although AFM is a suitable technique for the visualization of GNPs, it is poor from a statistical 
point of view as only tens or hundreds of particles can be realistically counted. Nanoparticle 
Tracking Analysis (NTA) instead verifies the size distribution of the GNPs based on 
measurement of the diffusion coefficient of many GNPs in a dispersion and also estimate the 
concentration of GNPs.  
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Figure 3. 1 AFM images of 30nm (A), 15nm (B) and 40nm (C) GNPs on mica. Distributions of gold particles shown in 
panels D (30nm), E (15nm) and F (40nm) respectively were obtained combining the particle maximum height from 
several AFM images (blue lines). The data from N nanoparticles were fitted to a Gaussian distribution (orange dots) to 
determine the most likely size of particles (Peak centre) and the standard deviation of the distribution (σ). 
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Figure 3. 2 Size distribution of GNPs by NTA.30nm (A), 15nm (B) and 40nm (C).  The 500X diluted concentration of 
(A), (B) and (C) was 2.38×108particles/ml, 2.94×108particles/ml and 3.77×108particles/ml respectively. 
The peak of the distributions obtained by NTA from the same samples discussed above was 
27.5nm, 22.5 nm and 38.8nm for the 30 nm, 15 nm and 40nm dataset respectively (Figure 3.2). 
Compared with the data obtained by AFM, the results for the 30nm GNPs and 40nm BBI GNPs 
were closer to the expected values. However, the estimation of the size for the 15nm batch by 
NTA was 22.5nm, which is 7.5nm bigger than the expected size. This discrepancy may be due 
to aggregates of GNPs in solution or due to the limited accuracy of NTA measurements, 
especially for very small particles.  
The concentration of the three sets of GNPs was measured by NTA as 2.94×108particles/ml 
(15nm), 2.38×108particles/ml (30nm), and 3.77×108particles/ml (40nm) respectively. 15nm, 
30nm and 40nm GNPs were diluted with Milli-Q water in the proportion of 1:500, therefore, 
the actual concentration of 15nm, 30nm and 40nm is 1.47×1011particles/ml, 
1.19×1011particles/ml and 1.89×1011particles/ml respectively. 
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3.1.3 Characterization of gold nanoparticles by DLS 
 
The average size of each set was calculated according to scattering intensity distributions. The 
measured mean GNPs sizes (Z-average) of 15nm, 30nm and 40nm were 13.97nm, 27.88nm 
and 39.16nm respectively (Figure 3.3). All the measurements showed that the three sets of 
GNPs were monomodal (only one peak) and monodisperse (narrow width of distribution). 
These results confirmed the measurements obtained with AFM and, in part, with NTA. 
 
 
 
                                   
Figure 3. 3 GNPs size distribution by DLS. (A) 15nm, (B) 30nm and (C) 40nm. 
Considering that the concentration at which particles are measured is less critical in DLS than 
NTA, that DLS takes into account the hydrodynamic behaviour of a very large number of 
particles compared to AFM and NTA, and that in case of monodispersed samples DLS is 
considered the most accurate way to assess particle size, we concluded that this was the best 
estimate of particles size. The size measurement was therefore very close to the expected size 
for all three samples. 
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3.1.4 Characterization of gold nanoparticles by UV-vis 
 
Based on multipole scattering theory, the size of GNPs can be estimated by absorbance spectra 
in the visible range. The GNPs solution were measured by UV-vis spectrophotometry to obtain 
the absorption spectra shown in Figure 3.4. 
The wavelength peak of absorbance of GNPs is size-dependent. The absorbance values for 
15nm GNPs, 30nm GNPs and 40nm BBI GNPs were 0.932, 0.8874 and 0.907 with peaks at 
521.9nm, 525.2nm and 527.3nm respectively.  
The peak absorbance for 30nm GNPs and 40nm BBI GNPs were at 525.2nm and 527.3nm 
respectively, therefore, the GNPs diameter based on Equation 2.1 was 32.6nm and 39.4nm, 
which is close to the expected size of 30nm and 40nm.  
Since Equation 2.1 is optimal for particles larger than 25nm, Equation 2.2 was used instead to 
estimate the size of the GNPs batch with expected size of 15nm. The measured peak absorbance 
was 0.866, resulting in GNPs diameter calculated from Equation 2.2 of 17.7nm, close to the 
expected size of 15nm. 
 
 
 
Figure 3. 4 UV-vis spectra of GNPs of 15nm, 30nm and 40nm. 
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Generally, the calculated diameters of the three sets of GNPs were 17.7nm, 32.6nm and 39.4nm 
according to Equations 2.1 and 2.2. It is known that the model is prone to an error of about 6%, 
hence, the calculated values fall within the range of the expected sizes. 
Expect size (nm) AFM(nm) NTA(nm) DLS(nm) UV-vis(nm) 
40 37.8 38.8 39.16 39.4 
30 26.2 27.5 27.88 32.6 
15 18.8 22.5 13.97 17.7 
Table 3. 1 Summary of GNPs characterization. 
In conclusion, the three sets of gold nanoparticles (15nm and 30nm GNPs were synthesized in 
the lab, 40nm GNPs was bought from BBI solution) were characterized by AFM, NTA, DLS 
and UV-vis (Table 3.1). Those techniques provide the size, the morphology and the 
concentration of GNPs in terms of visual observation, diffusion coefficient and multipole 
scattering theory. All the results show that all the batches of GNPs have expected sizes, and 
the lab-made GNPs (15nm and 30nm) have good distribution and morphology as BBI solution 
GNPs (40nm). Nevertheless, the excess gold chloride of lab synthesised GNPs has to be 
removed, and the buffer was exchanged in this case with water. The commercial GNPs, 40nm 
BBI GNPs, are more suitable for subsequent experiments that make use of proteins which are 
dissolved in salt buffers. Considering the salt stability, the BBI GNPs were used in the 
subsequent study of proteins adsorption to GNPs and proteins assembly on GNPs. 
3.2 Protein recombinant synthesis, chemical modification and assembly 
 
This section includes all the results on the protein biochemistry done in preparation of the 
experiments reported in the next sections. This included recombinant synthesis, bio-
conjugation and assessment of the assembly properties of SNARE proteins and 
SpyTag/SpyCatcher. The single-cysteine recombinant SNARE proteins (including SNAP25C1, 
SyntaxinC1 and SynaptobrevinC1) were used for conjugation purpose. SNAP25C1 was linked 
to maleimide-Cy3, and the assembled complexes containing SNAP25C1-Cy3 were visible 
under UV light. The cysteine of SyntaxinC1 and SynaptobrevinC1 was conjugated with BSA 
through Sulfo-SMCC. The BSA-SNARE proteins were used to assemble GNPs as dimers. GST, 
SNARE fusion proteins (GST-SNAP25 and Nanolock) and SpyTag/SpyCatcher proteins were 
synthesized as a proof-of-concept for modular assembly of proteins on gold nanoparticles.  
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3.2.1 Purification of GST  
 
The GST is a popular and easy-obtained affinity tag for recombinant proteins. It was expressed 
as native element of pGEX-KG vector and eluted by excess of glutathione from glutathione 
affinity resins. GST has four cysteine that are thought to be involved in forming Au-S covalent 
bonds between thiol groups and GNPs which are investigate in section 3.3.1. The investigation 
of GST was done to study the effect of electrostatic force and covalent bond on GNPs 
conjugation, and to evaluate whether GST can be used as an interface protein in GST-SNAP25 
and GST-SpyCatcher to bind GNPs efficiently, which is one of the primary objectives of this 
work.  
 
                 
Figure 3. 5 The GST protein.  Lane 1. PM is the protein marker (BioRad, Precision Plus ProteinTM Dual Color). MW is 
molecular weight. 
The calculated molecular weight of GST is 28.6kDa. The lane 1 of Figure 3.5 showed that the 
recombinant protein expressed and purified as described in methods has a molecular weight 
which is slightly bigger than 25kDa, from which we concluded that the intense protein band of 
lane 1 is compatible with GST, whereas the higher molecular weight bands can be impurities 
or aggregates. 
3.2.2 Synthesis and characterization of single-cysteine recombinant SNARE proteins for 
chemical conjugation  
 
For the purpose of chemical cross-linking with thiol reactive reagents, the three elements of 
the neuronal SNARE complex, SNAP25, Synaptobrevin and Syntaxin, were mutated by 
introducing a single-cysteine residue and named SNAP25C1, SynaptobrevinC1 and 
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SyntaxinC1. All of these proteins were cloned in pGEX-KG vector and expressed in E.coli. A 
total of 1.5 ml with an estimated concentration (BCA colorimetric method) of 39µM, 49µM 
and 115µM respectively was obtained for each protein. In order to verify whether the purified 
proteins correspond to the expected molecular weight, 6µg of each of the purified protein were 
loaded on a SDS-PAGE gel. The calculated molecular weights of SNAP25C1, 
SynaptobrevinC1 and SyntaxinC1 are 24.5kDa, 7.28kDa and 8.97kDa respectively. The three 
proteins are shown in the SDS-PAGE gel (Figure 3.6) and they appear to be of the expected 
molecular weights. An extra band remained after the gel filtration in purified SyntaxinC1 and 
SynaptobrevinC1. The gel shows that the target bands and extra bands have very closed 
molecular weight, so that they might not viable for gel filtration separation. Later it was found 
that these do not interfere with the assembly properties of SNAREs and are likely to be 
impurities from the original bacterial lysate. 
 
   
Figure 3. 6 SDS-PAGE gel of purified SNARE proteins, PM: protein marker (BioRad, Precision Plus ProteinTM Dual 
Color), 1: SNAP25C1, 2: SynaptobrevinC1, 3: SyntaxinC1. The arrows indicate the bands of the protein marker 
corresponding to 25 and 10kDa. MW is molecular weight. 
The newly designed SNARE proteins were mixed to verify their ability to assembly and in 
order to proof this, a heated and a non-heated samples were assessed by SDS-PAGE. In fact, 
SNARE complex is known to be resistant to SDS denaturation, however, when exposed to very 
high temperatures in presence of a loading buffer containing SDS, the complex is irreversibly 
disassembled into the three components. The successful assembly of SNAREs can be assessed 
by simply comparing the heated (complex completely disrupted) and non-heated sample 
(complex partly intact). 
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The expected molecular weight of the SNARE complex is 40.75kDa, however, there is a sharp 
band around 37kDa in lane 2 of Figure 3.7, non-heated sample. This slightly odd migration is 
likely due to the tight coiled-coil structure of SNARE complex which runs at different speed 
compared to the sum of the three linear proteins components. The non-heated sample also 
shows bands corresponding to Synaptobrevin and Syntaxin as they were used in excess. In the 
heated sample, lane 1 of Figure 3.7, the quaternary structure of assembled SNARE proteins 
was broken, and as a result the individual bands of SNAP25C1, SynaptobrevinC1 and 
SyntaxinC1 are clearly visible in line 1 (Figure 3.7).  
 
 
Figure 3. 7 SNARE complex assembled by newly synthesized proteins. PM is protein marker (BioRad, Precision Plus 
ProteinTM Dual Color). (1) heated SNARE complex, (2) non-heated SNARE complex. MW is molecular weight. 
The results in Figure 3.7 suggests that the newly synthesized SNAREs are capable of assembly 
and therefore can be potentially used for bio-conjugation, such as of GNPs, fluorophores or 
protein domains, by simple mixing. Thanks to SNARE complex unusual stability, it is worth 
noting that assembly can be assessed simply by SDS-PAGE. 
3.2.3 Synthesis and characterization of SNARE proteins fusions 
 
Neuronal SNARE proteins form a ternary complex made of SNAP25, Syntaxin and 
Synaptobrevin. In order to assemble two elements, for example GNPs, in a binary way, we 
expressed a Syntaxin and Synaptobrevin fusion into a single polypeptide, named Nanolock. 
Syntaxin is at the N terminal of Nanolock whereas Synaptobrevin is at the C terminal.  
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A GST-SNAP25 fusion was also made to adsorb SNAP25 onto GNPs, following the 
observation that GST binds to gold with high affinity (see section 3.3.4 and 3.3.5). A GST-
SNAP25 fusion was purified by elution with glutathione excess from glutathione affinity resin. 
GST-SNAP25 and Nanolock were mixed to verify whether they were able to form a SNARE 
complex.  
 
                                                                            
Figure 3. 8 SDS-PAGE of GST-SNAP25 and Nanolock. In both A and B, PM is the protein marker (BioRad, 
Precision Plus ProteinTM Dual Color). Lane 1 of A is GST-SNAP25, lane 1 of B is Nanolock. The insert in panle B shows 
a schematic of the Nanolock design (Ferrari, Darios et al. 2010). MW is molecular weight. 
The calculated molecular weight of GST-SNAP25 and Nanolock were 49kDa and 17kDa 
respectively and their identity was confirmed by SDS-PAGE (Figure 3.8).  
GST-SNAP25 and Nanolock were expected to form a SNARE complex which has a molecular 
weight of about 67kDa. In Figure 3.9, lane 2 showed that GST-SNAP25 was degraded which 
was visible by low molecular weight band, it was probably because of long time storage and 
refreeze, nevertheless, the partially-degraded GST-SNAP25 was still able to form a SNARE 
complex (lane 3) with Nanolock, as confirmed by the migration of the band corresponding to 
a molecular weight between 50kDa and 75kDa.  
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Figure 3. 9 SNARE complex assembled by GAT-SNAP25 and Nanolock. 1. Nanolock. 2. GST-SNAP25, compare 
with the GST-SNAP25 of Figure 3.8, GST-SNAP25 of this experiment was partially degraded, however, the degraded 
GST-SNAP25 was still able to form SNARE complex with Nanolock in lane 3. The expected molecular weight of the 
complex is about 67kDa. PM is the protein marker (BioRad, Precision Plus ProteinTM Dual Color). The according 
molecular weight (MW) of protein marker was labelled on the left. 
3.2.4 Synthesis and characterization of SpyCatcher/SpyTag Protein  
 
SpyCatcher and SpyTag are a pair of proteins engineered from Streptococcus pyogenes (Spy) 
that are able to form isopeptide bonds (Figure 3.10) by simple mixing. This covalent peptide 
interaction is a simple and powerful tool for bioconjugation(Kang and Baker 2011). In this 
project, the recombinant SpyCatcher and SpyTag are used for the bioconjugation to GNPs, 
SpyTag has a molecular weight of 1.76kDa, which makes it difficult to purify from bacterial 
lysates. However, a GST fusion of SpyTag which has larger molecular weight was easily 
obtained and used as a proof-of-concept for conjugation of GST-SpyTag fusions to SpyCatcher. 
SpyCatcher and GST-SpyCatcher were also obtained, the second was designed to be adsorbed 
to GNPs through GST-gold interaction (see 3.3.6).  
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Figure 3. 10 Purified SpyCatcher and GST-SpyTag. A. 1. SpyCatcher and GST-SpyTag bound by isopeptide bonds, 2. 
GST-SpyTag, 3. SpyCatcher, PM is the RunBlue prestained dual colour protein marker. B. the formation of isopeptide 
bonds ((Zakeri, Fierer et al. 2012). 
The calculated molecular weights of SpyCatcher and GST-SpyTag are 12kDa and 28kDa 
respectively. The isopeptide bonds between SpyCatcher and GST-SpyTag should give a 
protein of about 40kDa. In the lane 3 of Figure 3.10, it seems that the molecular weight of 
SpyCatcher is bigger than 15kDa, this poor migration could because of non-fresh running 
buffer, or the SpyCatcher was still in a stretched status so that it run slower. The lane 1 of 
Figure 3.10 has a band around 40kDa, which indicated that SpyCatcher and GST-SpyTag were 
able to form isopeptide bonds. 
3.2.5 Reduction of thiol groups for subsequent chemical conjugation 
 
Cysteines were used to react some of the proteins described above with maleimide activated 
chemicals. However, the sulfhydryl is easily oxidized in the daily storage or can form 
disulphide bonds (S-S). Dithiothreitol (DTT), β-mercaptoethanol (β-ME), and Tris(2-
Carboxyethyl)-Phosphine Hydrochloride (TCEP·HCl or TCEP) are all common sulfhydryl 
protective reducing agents. TCEP·HCl is stronger and more stable than DTT and β-
ME(Konigsberg 1972). On the other hand, both of DTT and β-ME contain sulfhydryl which 
might introduce extra reaction with maleimide, therefore, TCEP·HCl was used as the reducing 
reagent in this project. The incubation time and dose of TCEP·HCl, were investigated to 
determine optimal conditions.      
The calculated molecular weights of SNAP25C1, SynaptobrevinC1 and SyntaxinC1 are 
24.5kDa, 7.28kDa and 8.97kDa respectively, and all of them have one cysteine. The minimum 
molecular weight of protein marker (BioRad, Precision Plus ProteinTM Dual Color) is 10kDa 
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which is slightly larger than SynaptobrevinC1 and SyntaxinC1. It is difficult to observe 
accurate position of SynaptobrevinC1 and SyntaxinC1 based on protein marker. Hence 
SNAP25C1 rather than the other two was used to determine the reduction time (Figure 3.11) 
and amount of TCEP (Figure 3.12) by estimating the intensity of the band at the expected size, 
versus the one of dimers due to disulphide bonds formation.  
 
                             
Figure 3. 11 Optimization of TCEP incubation time. The reduction lasted for 1. overnight, 2. 8 hours, 3. 5 hours, 4. 3 
hours, 5. 1 hour, 6. 0 hour. PM is protein marker (BioRad, Precision Plus ProteinTM Dual Color). 12% SDS-PAGE, 
170V, 55 minutes. MW is molecular weight. 
In figure 3.11 the samples were prepared by SDS loading buffer without any reducing agent 
such as β-mercaptoethanol, therefore the disulfide bonds were only broken by 1mM TCEP was 
added prior to loading. Lane 6 shows non-reduced SNAP25C1, which is present only in the 
form of dimers (S-S bonds). Lane 1 shows the majority of SNAP25C1 was broken into 
monomers after overnight reduction by TCEP. Between 5 and 8 hours incubation, the majority 
of SNAP25C1 was reduced, but the reduction was not as good as overnight incubation. 
Between 1 and 3 hours reduction, approximately half SNAP25C1 was still dimerized. 
Therefore SNAP25C1, SynaptobrevinC1 and SyntaxinC1 were all reduced by TCEP overnight 
before performing the conjugation steps described below.  
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Figure 3. 12 Optimization of the amount of TCEP. The concentration of TCEP is 1. 1mM, 2. 0.5mM, 3. 0.1mM, 4. 0mM, 
PM is protein marker (BioRad, Precision Plus ProteinTM Dual Color). 12% SDS-PAGE, 170V, 55 minutes, SDS loading 
buffer without β-mercaptoethanol. MW is molecular weight. 
SNAP25C1 was incubated overnight with different concentration of TCEP as shown in Figure 
3.12. The majority of disulfide bonds were reduced by 1mM TCEP after an overnight 
incubation whereas lower concentrations of TCEP were not enough to reduce the disulfide 
bonds of SNAP25C1, therefore we used 1mM TCEP in subsequent experiments. 
3.2.6 Cross-linking of SNARE Proteins 
 
SNAREs were cross-linked to either maleimide-activated fluorophore Cy3 or BSA for gold 
nanoparticle assembly in section 3.5. All the cysteine-containing proteins used in this section 
were reduced by 1mM TCEP overnight before the cross-linking reaction. 
SNAP25C1 linked to maleimide-Cy3 
Maleimide-Cy3 is a fluorescent molecule used for labelling proteins through maleimide at 
cysteine residues. In this project maleimide-Cy3 was combined with reduced SNAP25C1. 
Because of Cy3 fluorescence, the SDS-PAGE gel was imaged using UV illumination firstly 
(Figure 3.13A), and then it was stained by Instantblue (Figure 3.13B). The molecular weight 
of Cy3 is 791.0 Da, so that the difference of molecular weights between SNAP25C1 and 
SNAP25C1-Cy3 is negligible. Therefore, the bands around 25kDa (Figure 3.13) were 
considered compatible with both SNAP25C1-Cy3 and unconjugated SNAP25C1. 
The synthesized SNAP25C1-Cy3 was purified by gel filtration to remove the excess 
maleimide-Cy3. SNAP25C1-Cy3 size is very close to SNAP25C1 so we were not able to 
separate them by gel filtration. With the aim to calculate the concentration of SNAP25C1-Cy3, 
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the absorbance of purified SNAP25C1-Cy3 was measured by Nanodrop (Thermo Scientific) 
from 250nm to 650nm. The absorbance value at 280nm and 550nm were 0.942 and 3.26 
respectively. According to Equation 2.3 and 2.4, the concentration of SNAP25C1-Cy3 and 
SNAP25C1 were estimated as 20.5µM and 24µM respectively. Based on Equation 2.5, the 
concentration ratio of [Cy3]/[SNAP25C1] was calculated as 0.85, suggesting that 85% 
SNAP25C1 was labelled with Cy3. 
SNAP25C1-Cy3 was incubated with SynaptobrevinC1 and SyntaxinC1 to confirm whether 
they were able to form a SNARE complex. The heated complex was disassembled and loaded 
as a control, hence, based on the protein marker, the bands around 25kDa and 10kDa of lane 2, 
Figure 3.13 were SNAP25C1-Cy3, SynaptobrevinC1 or SyntaxinC1. The non-heated complex 
(lane 3 of Figure 3.13) shown that the SNARE complex was visible under UV light and stained 
gel. However, the SynaptobrevinC1 or SyntaxinC1 might dimerize through disulphide bonds 
and dimers of SynaptobrevinC1 or SyntaxinC1 could form SNARE complexes, as evidenced 
by a double band near the size expected for the SNARE complex in lane 3, Figure 3.13. 
                                                             
Figure 3. 13 SDS-PAGE of SNAP25C1-Cy3. (A) SDS-PAGE gel under UV light. (B) The same SDS-PAGE gel with A was 
stained with Instantblue. 1. SNAP25C1-Cy3 only 2. boiled complex: SNAP25C1-Cy3 assembled with Synaptobrevin -GSC 
and SyntaxinC1. 3:non-boiled complex. PM is the protein marker (BioRad, Precision Plus ProteinTM Dual Color). The 
molecular weight (MW) of fluorescent bonds (A) and protein marker (B) were labelled on the left.  
Figure 3.13 also suggests that SNAP25C1 was successfully linked to maleimide Cy3 as 
evidenced in lane 1 by the fluorescent band compatible with SNAP25 size. However, intense 
fluorescence at lower molecular weight suggests there is some excess of Cy3 that was not 
entirely removed after purification. As a consequence of this, we believe the conjugation 
efficiency is probably less than the estimated 85%.  
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Optimization of SNARE-BSA synthesis  
SynaptobrevinC1 and SyntaxinC1 were combined with BSA through Sulfo-SMCC 
(sulfosuccininidyl 4-[N-maleimidomethyl]cyclohexane-1-carboxylate) which is a water 
soluble heterobifunctional crosslinker that contains N-hydroxysuccinimide (NHS) ester and 
maleimide groups that allow covalent conjugation of amine- and sulfhydryl- containing 
molecules(Lee and Hoover 1995). In this experiment, the first step was incubation of 
SynaptobrevinC1 or SyntaxinC1 with Sulfo-SMCC. Second, BSA was linked to activated 
SynaptobrevinC1 or SyntaxinC1. This reaction order was expected to achieve the right 
orientation of SNARE-BSA conjugates: BSA links to the C-terminal of SynaptobrevinC1 or 
SyntaxinC1. The C-terminal of SynaptobrevinC1 and SyntaxinC1 present one cysteine which 
is expected to react with the maleimide group of Sulfo-SMCC, whereas BSA was combined to 
activated SynaptobrevinC1 or SyntaxinC1 through NHS ester and one of the several amines. 
In this configuration, the N-terminal of SNAREs would be far apart from the BSA and the 
SNARE-BSA conjugates would possibly assemble into a SNARE complex, which in fact forms 
from the N-terminal of SNAREs to C-terminal (Fasshauer and Margittai 2004).  
In order to find the best conditions to synthesize SNARE-BSA conjugates in the right 
orientation, the reaction of maleimide/sulfhydryl and NHS ester/amine were optimized 
independently, in terms of incubation time and amount of reactant.  All the optimized 
conditions were listed in Table 3.2. 
  optimization conditions 
Sulfo-SMCC concentration 1mM 5mM 10mM   
BSA concentration 10µM 30µM 40µM   
NHS-ester incubation time overnight 5 hours 1 hour 0.5 hour 
maleimide incubation time overnight 5 hours 1 hour 0.5 hour 
Table 3. 2 The optimization conditions of SNARE-BSA conjugates. The best conditions were bold. 
Both SynapbrevinC1 and SyntaxinC1 were linked to BSA after activation in the same way, 
therefore, SyntaxinC1 was used as a model for optimization. Based on previous results (see 
section 3.2.5), SyntaxinC1 was reduced by 1mM TCEP overnight before reacting with Sulfo-
SMCC. 
Although SyntaxinC1 was reduced by TCEP, sulfhydryl group could potentially oxidize again 
during Sulfo-SMCC reaction to form S-S bonds which would compete with maleimide reaction, 
and this would result in less SyntaxinC1-BSA conjugate. For this reason, maleimide reactions 
with or without TCEP were compared to assess whether it is essential to keep TCEP in reaction 
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or it is possible to remove it before the reaction. In both tests, TCEP was removed by desalting 
columns after the reaction between maleimide and cysteine happenes, at the same time of 
removal of Sulfo-SMCC excess. Therefore, there was no need to investigate whether TCEP 
might also affect the reaction between NHS ester and amine.   
 
                                                                        
Figure 3. 14 Maleimide incubation with or without TCEP. 1. Reduced SyntaxinC1. 2. BSA. 3. SyntaxinC1-BSA (without 
TCEP). 4. SyntaxinC1-BSA (with TCEP). PM is Protein marker (BioRad, Precision Plus ProteinTM Dual Color). 12% 
SDS-PAGE, 170V, 55minutes. MW is molecular weight. 
SyntaxinC1-BSA conjugate is indicated by arrows in Figure 3.14. These are proteins with a 
molecular weight slightly above BSA and present at a lower concentration compared to 
unreacted BSA. Therefore they appear in the gel as a faint band slightly above BSA. Lane 3 
(without TCEP) has slightly less conjugates than lane 4 (with TCEP), therefore, we concluded 
that it is beneficial, or at least not problematic, to keep TCEP in the maleimide reaction, which 
also removes one step from the conjugation flow-chart.  
Sulfo-SMCC is a heterobifunctional crosslinker containing maleimide and NHS ester, and 
since SyntaxinC1 has one cysteine but several amine groups, it is potentially able to cross-link 
more than one Sulfo-SMCC molecule through reaction of maleimide/cysteine and amine/NHS-
ester at the same time. Moreover, BSA has many amine groups that could be combined with 
several activated SyntaxinC1. Hence, the concentration of Sulfo-SMCC and BSA were 
optimized to avoid over-crosslinking. The results are shown in Figure 3.15 and Figure 3.16 
respectively. Besides concentrations, also reaction times were carefully optimized. In fact, 
maleimide and NHS ester would be hydrolysed slowly in aqueous solution resulting in loss of 
reaction activity(Lee and Hoover 1995), therefore, the two parts of the crosslinker, maleimide 
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and NHS ester, should react before the hydrolytic degradation. The incubation time of each 
part of the crosslinking reaction was optimized and shown in Figure 3.17 and 3.18 respectively.       
 
 
                                                                           
Figure 3. 15 Syntaxin-BSA was produced by different amount of Sulfo-SMCC. 1. Reduced SyntaxinC1. 2. SyntaxinC1-
BSA (1mM Sulfo-SMCC). 3. SyntaxinC1-BSA (5mM Sulfo-SMCC). 4. SyntaxinC1-BSA (10mM Sulfo-SMCC). 5. BSA. 
PM is the Protein Marker (BioRad, Precision Plus ProteinTM Dual Color). 12% SDS-PAGE, 170V, 55minutes. MW is 
molecular weight. 
Figure 3.15 shows the optimization of Sulfo-SMCC concentration. 1mM Sulfo-SMCC reaction 
has the best yield of SyntaxinC1-BSA, whereas 5mM and 10mM Sulfo-SMCC reaction had 
less SyntaxinC1-BSA conjugates than 1mM and more high molecular weight conjugates. This 
is likely because the high concentration of Sulfo-SMCC yield over-crosslinking, consequently, 
one SyntaxinC1 was possibly combined with two BSA molecules thus originating the high 
molecular weight conjugates. The more Sulfo-SMCC added, the higher molecular weight 
conjugates were produced. From the results of figure 3.15 we determined that 1mM Sulfo-
SMCC was the best concentration to be used in the crosslinking reaction.  
Different concentrations of BSA (10µM, 30µM and 40µM) were incubated with 30µM 
SyntaxinC1-SMCC to find the best reaction conditions. In figure 3.16, 10µM BSA reaction 
gave the least SyntaxinC1- BSA conjugates. 30µM BSA and 40µM BSA have nearly the same 
amount of SyntaxinC1- BSA conjugates. However, there are several high molecular weight 
conjugates in the 40µM BSA reaction, possibly due to the over-crosslink between BSA and 
activated SyntaxinC1. We concluded that 30µM BSA was the best compromise to be used in 
the reaction. 
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Figure 3. 16 Optimization of different amount of BSA. Lane 1. Reduced SyntaxinC1, lane 2. BSA, lane 3. 10mM BSA 
incubation, lane 4. 30mM BSA incubation, lane 5. 40mM BSA incubation. PM is the protein marker (BioRad, Precision 
Plus ProteinTM Dual Color). 12% SDS-PAGE, 170V, 55minutes. MW is molecular weight. 
Figure 3.17 shows the optimization of incubation time for SyntaxinC1 and Sulfo-SMCC 
reaction. 1 hour incubation and 5 hours incubation resulted in the same amount of conjugates, 
which is larger than the amount at 0.5 hour. The overnight incubation has the least amount, this 
is likely because Sulfo-SMCC have been hydrolyzed in aqueous buffer during overnight 
incubation. Therefore, 1 hour incubation was considered long enough for linking Sulfo-SMCC 
and SyntaxinC1. 
 
              
Figure 3. 17 Optimisation of the incubation time of the maleimide reaction. Lanes 1, 3, 5 and 8 are SyntaxinC1-Sulfo-
SMCC which have been incubated for 0.5 hour, 1 hour, 5 hours and overnight respectively. Lanes 2, 4, 6 and 9 are 
SyntaxinC1-BSA conjugates made from lane 1, 3, 5 and 8 respectively. Lane 7 is BSA only. PM is the protein marker 
(BioRad, Precision Plus ProteinTM Dual Color). 12% SDS-PAGE, 170V, 55minutes. The molecular weight (MW) of 
protein marker was labelled on the right. 
Figure 3.18 shows the optimization of incubation time between activated SyntaxinC1 and BSA. 
The amount of conjugates is the same at different incubation times. It indicates that reaction 
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between SyntaxinC1-Sulfo-SMCC and BSA is very quick and efficient. Therefore we 
considered 0.5 hour incubation sufficient for the following experiments.  
 
Figure 3. 18 Optimization of incubation time for NHS ester reaction. Lane 1. Reduced SyntaxinC, lane 2. BSA only, lane 
3, lane 4, lane 5 and lane 6 are 0.5 hour, 1 hour, 5 hours and overnight incubation respectively, PM is protein 
marker(BioRad, Precision Plus ProteinTM Dual Color). 12% SDS-PAGE, 170V, 55minutes. MW is molecular weight. 
In summary, the best conditions for synthesizing BSA-SNARE conjugates were: 50 µM of 
SyntaxinC1 (or SynaptobrevinC1) mixed with 1mM Sulfo-SMCC for 1 hour incubation at 
room temperature. The excess Sulfo-SMCC was then removed by Zeba desalting columns. 30 
µM of the mixture was then added to 30µM BSA for 0.5 hour incubation at room temperature.  
In this condition, the reaction achieved the highest yield.     
We then verified whether the crosslinking of SyntaxinC1 to BSA by Sulfo-SMCC was 
happening in the desired orientation, which is maleimide reaction with the cysteine on the C-
terminal of SNAREs first and then NHS on any amino group of BSA. As it was described in 
the introduction, the quaternary structure of SNARE complex is formed from the N-terminal 
to C-terminal of SNARE proteins. Both for SynaptobrevinC1 and SyntaxinC1 the cysteine is 
at the end of C-terminal that was intended to link to BSA. The reason of this design is that we 
want to assemble together Syntaxin-BSA and Synaptobrevin-BSA in presence of SNAP25C1-
Cy3 (see section 3.5) and this would be facilitated if the BSA is at the C-terminal of the 
SNAREs, as this wouldn’t interfere with the priming of the assembly.  
The crosslinking reaction was performed at pH7.2 which is suitable for both NHS-ester and 
maleimide reaction. BSA has an active Cysteine (Cys-34) which is available to link to the 
maleimide group of Sulfo-SMCC. Therefore, the N-terminal amine groups of SynaptobrevinC1 
or SyntaxinC1 could link to BSA through Sulfo-SMCC in the wrong orientation. In this 
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configuration, the SNARE-BSA might not be able to form SNARE complex because of steric 
hindrance. 
                                    
 
Figure 3. 19 The orientation of SNARE-BSA conjugates. 1. SynaptobrevinC1-Sulfo-SMCC. 2. SynaptobrevinC1-BSA. 3. 
Synaptobrevin-Sulfo-SMCC. 4. Synaptobrevin-BSA. 5. SyntaxinC1-Sulfo-SMCC. 6. SyntaxinC1-BSA. 7. Syntaxin-Sulfo-
SMCC. 8. Syntaxin-BSA. 9. BSA. PM is the protein marke(BioRad, Precision Plus ProteinTM Dual Color)r. 12% SDS-
PAGE, 170V, 55minutes. MW is molecular weight. 
We performed the conjugation to BSA using Synaptobrevin and Syntaxin without the cysteine 
residues and compared with the ones with a single cysteine. Lane 4 and lane 8 (Synaptobrevin 
and Syntaxin without SH groups) of Figure 3.19 show that there is a negligible (if any) amount 
of Synaptobrevin-BSA and Syntaxin-BSA compared to lanes 2 and 6. These results suggest 
that the amount of SNARE-BSA conjugates obtained by cross-linking of the NHS moiety to 
SNARE’s amino groups is negligible compared to the maleimide-SH reactivity.  
Also, it is known that a reaction between amine and maleimide can happen, but it is much 
slower than the reaction between sulfhydryl and maleimide, and it generally happens only at 
very high concentration of maleimide (100mM)(Phelps, Enemchukwu et al. 2012). This 
experiment, also confirms that this is unlikely to happen in our conditions as the synthesized 
SynaptobrevinC1-BSA and SyntaxinC1-BSA in lane 2 and lane 6 of Figure 3.19 show that the 
reaction between sulfhydryl and maleimide is quicker than NHS-ester and amine. In conclusion, 
we can say that SNARE-BSA conjugates were most likely assembled in the desired orientation, 
and could be therefore expected to be usable in subsequent assembly reactions (see section 3.5). 
 
 
 
1 2 3 
 
4 5 PM 6 7 8 9 
SyntaxinC1-BSA 
conjugate 
Synaptobrevin-BSA 
conjugate 
       250 
       150 
       100 
       75 
       50 
       37 
       25 
       20 
       15 
      10 
MW(kDa) 
73 
 
3.3 Adsorption of protein on gold nanoparticles 
 
Protein-GNPs conjugates are commonly used for biological applications, such as biosensor 
design, drug delivery and cancer therapy. Due to these promising applications based on the 
immobilization of proteins on to GNPs, many investigations have been reported on 
understanding the mechanism of protein adsorption on GNPs. However, the studies on the 
mechanism are still not comprehensive. In this section, the role of electrostatic interaction in 
GNPs/proteins adsorption was investigated by taking GST as an example. Also, a comparison 
of the adsorption of GNPs/GST with GNPs/NEM-GST was done to understand the role of 
thiols on GNPs/proteins interaction. We also demonstrated that proteins fused to GST are still 
able to accomplish their function after adsorption: GST-SNAP25 on GNPs could form a 
SNARE complex with Nanolock, and GST-SpyCatcher on GNPs could form isopeptide bonds 
with GST-SpyTag. These two binary protein systems could be potentially used to decorate and 
assemble GNPs in a highly modular way, which is the overarching theme of this work.  
3.3.1 Equilibrium binding of GST to GNPs 
 
The equilibrium binding of GST to GNPs was measured at different pH values (6.0, 6.5, 7.3, 
and 8.0) using dynamic light scattering (DLS) to investigate the effect of electrostatic force in 
GST-GNPs interaction. The affinity of binding was described in terms of affinity dissociation 
constant (KD) and the maximum increase of particle hydrodynamic diameter (∆dMAX) at high 
concentration of GST. This also gives an estimate of the maximum size of monolayer which 
formed on the surface of GNPs. Figure 3.20 A-D show plots of particle size increase (∆d) 
versus concentration of GST, drawn based on DLS measurements.  
DLS data were fit to Equation 1.6 using nonlinear least-squares, and KD and ∆dMAX were 
calculated. Figure 3.20 E shows the KD and ∆dMAX at the four pH values. pH mildly affected 
the binding affinity of GST to GNPs. The binding has the highest ∆dMAX at pH6.5 (10.2nm), 
while at this pH, it has the lowest KD (0.053µM) suggesting that this is the pH, among those 
tested, at which GST binds more effectively.  Opposite to this, at pH8.0, ∆dMAX has the lowest 
value (7.5nm) and the highest KD (0.078µM). This is likely due to better binding at pH close 
to the isoelectric point of the protein (pI of GST is 6.65 as calculated using bioinformatics tools 
available at http://web.expasy.org/protparam/) which minimizes the number of charges on the 
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protein and probably helps orientation and binding. This is discussed more in depth in section 
3.3.3. 
 
 
 
Figure 3. 20 DLS measurements of equilibrium binding of GST to GNPs. The data was fitted to the Hill equation at 
different values. (A) pH6.0. (B) pH6.5. (C) pH7.3. (D) pH8.0. Data points (black dots) are the average values of three 
replicate measurements fitted (dash line) to the Hill equation. The error bars represent the standard deviation of the three 
replicates. (E) KD (blue line) and ∆dMAX (orange line) were calculated from Equation 1.6. The lowest KD value 
corresponds to the best affinity binding of GST to GNPs. The largest ∆dMAX corresponds to the maximum amount of GST 
adsorbed to GNPs. 
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3.3.2 Mapping surface charges on GST 
 
The pH affects the distribution of charges on GST surface, furthermore, the charge may affect 
the affinity binding of GST to GNPs. Adaptive Poisson-Boltzmann Solver (APBS)(Konecny, 
Baker et al. 2012) was used to map the electrostatic surface potential of GST. The calculated 
potential was presented in different colours, blue is positive, and red is negative. In Figure 3.21, 
panels A, B, C and D show that pH6.0 and pH6.5 have excess of positive potential, while pH7.3 
and pH8.0 have net negative potential. This is consistent with the calculated pI of 6.65 
(http://web.expasy.org/protparam/), so net charges of GST at pH6.0 and pH6.5 below pI were 
positive whereas pH7.3 and pH8.0are above pI and therefore negative.  
 
 
Figure 3. 21 Electrostatic surface potential distribution of GST (the protein data bank ID of GST is 1UA5) calculated 
using APBS and displayed by Chimera(Vitozzi, Lapierre et al. 2002) at (A) pH6.0, (B) pH6.5, (C) pH7.3, (D) pH8.0. The 
blue indicates positive surface potential and the red represents negative surface potential. 
GNPs surface has net negative charges due to citrate capping, likely contributing to GST 
adsorption onto GNPs by electrostatic force. Therefore, it can be deduced that GST with net 
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positive charges has higher affinity binding, which gives low KD value and high ∆dMAX. Figure 
3.21 showed that pH6.5 gives the lowest KD (0.053µM) and highest ∆dMAX (10.218nm). At 
pH8.0, GST has maximum net negative charges tested and showed highest KD (0.078µM) and 
lowest ∆dMAX (7.493nm). However, there were different observations at pH6.0 and pH7.3. At 
pH6.0, it was expected the most positive charge would give the lowest KD and the highest 
∆dMAX. However, at pH6.0 the KD (0.075µM) is higher than pH6.5 (0.053µM) and pH7.3 
(0.054µM). At pH7.3, the KD (0.054µM) has the similar low level to pH6.5 (0.053µM). From 
the images of figure 3.21, the net positive charged GST (at pH6.0 and pH6.5) also has negative 
potential parts. The higher KD at pH6.0 (0.075µM) suggests that there are persistent negative 
charged parts of GST that result in low binding affinity, While, positively charged parts at 
pH7.3 still contribute to good binding, consequently, the KD (0.054µM) at pH7.3 was higher 
than expected based on net charge only. This is an indication that the distribution of the charges 
might be as important as the net charge. Nevertheless, the ∆dMAX at pH7.3 (7.945nm) is as low 
as pH8.0 (7.493nm) which suggests that there was a lower amount of GST adsorbed to GNPs. 
At pH6.0, although KD is high, the ∆dMAX is up to 9.8nm. Conclusively, the affinity of 
electrostatic binding of GST to GNPs is described by both KD and ∆dMAX, and the binding 
seems more efficient at pH close to the pI. It is worth noting that the residues of GST directly 
adsorbed to GNPs surface do not necessarily have the same charge of the overall charge of 
GST, suggesting that the distribution of charges is important and would be worth exploring, 
for example using molecular dynamics simulations. 
3.3.3 Zeta-potential measurement of GNPs-GST conjugates 
 
The electrostatic surface potential mapping describes the charge distribution of GST at 
different pH values (pH6.0, pH6.5, pH7.3 and pH8.0). Based on charge distribution, we 
evaluated the effect of electrostatic force on equilibrium binding of GST to GNPs. However, 
this was not a direct evidence of the charge of GNPs-GST conjugates. The overall electrostatic 
potential of GNPs-GST conjugates at different pH values (pH6.0, pH6.5, pH7.3 and pH8.0) 
was measured by Zeta-potential. Figure 3.22 shows that both GNPs-GST conjugates and naked 
GNPs were negatively charged. The conjugates made at pH6.0 were the least negatively 
charged (-19.18mV), followed by pH6.5 (-23.55mV), then pH7.3 (-33.40mV), and pH8.0 had 
the highest negative charge (-39.28mV). However, the surface charges of GNPs-GST at any 
pH was less negative than the charges of GNPs only (approximately -40mV). The surface 
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charges of GNPs-GST at pH8.0 (-38.28mV) were nearly the same of naked GNPs 
(approximately -40mV).   
 
Figure 3. 22 Zeta-potential of GNPs-GST (blue) and GNPs only (orange) at different pH values (pH6.0, pH6.5, pH7.3 and 
pH8.0). 
The Zeta-potential data suggest that pH6.0 and pH6.5, which are below pI (6.65) and therefore 
positive charged, did counteract the negative charge from the surface of GNPs, but only 
partially. Moreover, the pH7.3 and pH8.0, which are above pI (6.65), only have a few of 
positive charges which result in negligible compensation of the negative charges of GNPs only, 
which are highly negative charged (low potential of the orange lane across all pH). These 
findings further explain the conclusion that GNPs-GST conjugates at pH6.5 have best affinity 
and most strong binding likely due to less electrostatic repulsion existing between GST and 
GNPs. By contrast, at pH8.0, the electrostatic repulsion that exist between GST and GNPs 
likely led to weaker binding.  
The lowest KD (0.053µM) and highest ∆dMAX (10.218nm) were found at pH6.5 likely as this is 
very close to the pI of GST (6.65), GST has an almost neutral overall charge which generates 
the lowest electrostatic repulsion between GST and GST-GNPs surface causing the strongest 
binding.  
3.3.4 Binding kinetics of GST to GNPs 
 
Based on the mapping of surface charges and measurements of Zeta-potential, it was concluded 
that the binding between GST and GNPs was driven by electrostatic interactions. However, 
these findings did not provide any information on rates of GNPs/GST binding.  
-45
-40
-35
-30
-25
-20
-15
-10
-5
0
pH6 pH6.5 pH7.3 pH8
Ze
ta
-p
o
te
n
ti
al
 (
m
V
)
GNPs-GST GNPs only
78 
 
In order to study this, the increased in size of GNPs-GST was measured at different time by 
DLS at the optimum pH6.5 and at different concentrations of GST (0.02µM, 0.05 µM, 0.1 µM, 
0.2 µM and 0.5 µM).  
In Figure 3.23 (A- E) size increase (∆d) data versus time were plotted. The increase in size 
(black dots) was fitted to Equation 1.8 (dash line) and the kinetic constant of GST (K[GST]) at 
different concentrations was calculated. The maximum ∆d obtained at each concentration was 
also plotted versus the concentration of GST in Figure 3.23 (F) and the data fit to Hill equation 
as discussed above to confirm equilibrium binding data obtained previously. The resulting 
calculated KD (dissociation constant) was 0.056µM which is very close to the KD (0.053 µM) 
of Figure 3.20 (B) obtained by equilibrium binding studies. However, based on Figure 3.23 (F), 
∆dMAX was 7.6nm which is about 3nm less than the ∆dMAX of Figure 3.20 (B). The difference 
maybe from the different concentration range tested here which may give a less accurate 
estimate of the size at saturating concentration. In fact, in Figure 3.20 (B), the highest 
concentration of GST was 1.25µM, whereas the highest GST concentration of Figure 3.23 (F) 
was only 0.5µM. which might lead to inaccuracy while determining the ∆dMAX parameter, as 
the saturation of adsorption between GNPs and GST can be reached at concentrations higher 
than 0.5µM. Nevertheless, the affinity and the reaction rate of the adsorption are not affected 
by concentration range.  
Based on the measurements of Figure A-D, the K[GST] was plotted versus concentrations of 
GST in Figure 3.23 (G). The dataset in Figure E did not contribute to the calculation of K[GST] 
calculation as the association step has only few points, due to the fast adsorption at this 
concentration. According to Equation 2.6, Figure 3.23 (G) indicates that the association 
constant (Kon) of GST adsorption on GNPs was 0.0257 M-1·s-1, and the dissociation constant 
(Koff) of the adsorption was 0.0023 s-1.  
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Figure 3. 23 GST binding kinetic (A-E). The increased size (∆d) was plotted against time at different concentration of 
GST from 0.02µM to 0.5µM.  ∆d (black dots) was fitted (dash line) to Equation 1.8. (F) ∆d (black dots) was plotted 
against concentration and was fitted (dot line) to Equation1.6. The KD and ∆dMAX were calculated as 0.056µM and 
7.639nm. (G) K[GST] (black dots) was calculated from Figure 3.24(A-D) data and was fitted by Equation 2.6 (dot line). The 
equation of the linear trendline (y=0.0257x+0.0023) indicates that the Kon of the adsorption of GST to GNPs is 0.0257M-
1·S-1, and the Koff of the adsorption is 0.0023S-1. 
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3.3.5 Binding kinetics of NEM-GST to GNPs 
 
It is known that gold and thiol can form Au-S covalent bond(Hurst, Lytton-Jean et al. 2006). 
Each GST protein molecule has 4 cysteines (each cysteine has one sulphydric group) that could 
bind to GNPs though Au-S covalent bonds. Therefore, GST might be able to bind to GNPs by 
physisorption (electrostatic force) as well as chemisorption (Au-S covalent bonds). In order to 
study the contribution of chemisorption between GNPs and GST, the sulphur groups of GST 
were blocked by N- Ethylmaleimide (NEM).  
The availability of unreacted thiol groups of NEM-GST was quantified by Ellman’s Reagent 
comparing its reactivity to a standard curve (Figure 3.24) obtained with L-cysteine, the 
adsorption was measured by UV-vis at 412nm. 
 
Figure 3. 24 The standard curve of Ellman’s reagent. The adsorption value was fitted by linear trendline (the dot line, 
y=0.0019x+0.2712, R2=0.9925). 
The concentration of GST before and after NEM-blocking were measured by Nanodrop and 
were found to be 30.4µM and 30.06µM respectively. This indicated that GST was not lost  
during desalting to remove the excess NEM. The adsorption at Ellman’s reagent wavelength 
of NEM-GST and GST were 0.2534 and 0.5098 respectively. Based on the standard curve 
(Figure 3.24), no thiol groups were available in NEM-GST, whereas the estimated thiol 
concentration of GST was 125.6µM. Since each GST protein has 4 cysteines, this value would 
account for a GST concentration of 31.4µM, which was very close to the Nanodrop-measured 
value of 30.4µM. 
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The NEM-blocked GST (NEM-GST) was adsorbed onto GNPs at different concentration 
(0.02µM, 0.05 µM, 0.1 µM, 0.2 µM and 0.5 µM) at pH6.5 and  the increase in size of 
GNPs/NEM-GST conjugates were measured by DLS at different times, like in the previous 
section for unblocked GST. GNPs/NEM-GST binding data were plotted in Figure 3.25 (A-E). 
The increased sizes (black dots) were fitted to Equation 1.8 (dash line). K of NEM-GST at 
different concentration (0.02µM, 0.05 µM, 0.1 µM, 0.2 µM and 0.5 µM) was calculated by 
Equation 1.8 and KD (0.050µM) and ∆dMAX (6.2nm) of the adsorption between GNPs and 
NEM-GST were calculated from Figure 3.25 (F). KD (0.050µM) of GNPs/NEM-GST is slightly 
lower than KD (0.056µM) of GNPs/GST. Nevertheless, it could be considered close enough to 
conclude that SH groups do not contribute substantially to the binding affinity. The blocked 
cysteines on NEM-GST are not supposed to change the pI value or charge distribution either, 
as cysteines are hardly ionized at pH6.5 so a study of affinity at different pH was considered 
unnecessary. ∆dMAX (6.2nm) of GNPs/NEM-GST is 1.5nm less than ∆dMAX (7.6nm) of 
GNPs/GST which might be just due to an insufficient range of concentrations to determine this 
accurately.  
In order to calculate the rate constant K consistently, the K[NEM-GST] was plotted against 
concentrations of NEM-GST (Figure 3.25 (G) according to Figure A-D. The fit of Figure 3.25 
(G) indicates that the Kon of the adsorption between GNPs and NEM-GST was 0.0077 M-1·S-1, 
and the Koff of the adsorption was 0.003 S-1. Kon of GNPs/NEM-GST is lower than GNPs/GST 
and Koff of is only slightly lower. The results of Kon and Koff suggest that GST have a better 
binding rate to GNPs, therefore we can conclude that cysteines may play an important role in 
determining the binding rate or the binding affinity. 
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Figure 3. 25 NEM-GST binding kinetic (A-E). The increased size (∆d) against time was plotted at different concentration 
(0.02µM, 0.05 µM, 0.1 µM, 0.2 µM and 0.5 µM) of NEM-GST. The ∆d (black dots) was fitted (dash line) to Equation 1.8. 
∆d (black dots) against concentration of NEM-GST was plotted (F) and was fitted (dash line) to Equation 1.6. The KD 
and ∆dMAX of NEM-GST were calculated as 0.050µM and 6.161nm. (G) K[NEM-GST] (black dots)was calculated from 
Figure 3.26 (A-D) and was fitted to Equation 2.6 (dot line, y=0.0077x+0.003). The equation of (G) suggested that the Kon 
of NEM-GST is 0.0077M-1·S-1, and the Koff is 0.003S-1. 
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3.3.6 Displacement of GST from gold nanoparticles by β-Mercaptoethanol 
 
The comparison of KD and K of GST and NEM-GST showed that the sulphydric groups do not 
contribute to the affinity or binding rate. However, the thiols might play a role in enhancing 
the long-term stability of binding between protein and GNPs as suggested in(Rosi, Giljohann 
et al. 2006) We observed that GNPs precipitate in presence of thiol reagent (Figure 3.26), such 
as dithiothreitol (DTT) and β-Mercaptoethanol (β-ME), unless the GNPs are covered with 
proteins through chemisorption (Au-S bonds) that prevent thiols’ binding. GST is potentially 
able to bind to GNPs through thiols in the cysteine residues to form Au-S covalent bonds. By 
contrast, NEM-GST has no thiol available, so the only option for binding is physisorption 
(electrostatic interaction). Our hypothesis is that NEM-GST adsorbed onto GNPs could be 
displaced by β-ME and result in GNPs precipitation whereas GST could bind covalently and 
prevent particles precipitation.     
 
Figure 3. 26 GNPs tend to precipitate in the presence of β-Mercaptoethanol (β-ME). 
GST and NEM-GST were incubated with GNPs for different times and β-ME was added to 
GNPs/GST and GNPs/NEM-GST conjugates after the set time for an extra 20 minutes 
incubation. Then the absorbance at the Surface Plasmon Resonance (SPR) peak of GNPs/GST 
and GNPs/NEM-GST conjugates was measured. The size of GNPs/GST and GNPs/NEM-GST 
is about 47nm (Figure 3.20) which corresponds to a SPR peak around 530nm. The adsorption 
ratio of 530nm to 600nm (Ab530nm/600nm) was used to indicate the stability of the colloid, as an 
increase of the absorbance at 600nm is observed following aggregation. In Figure 3.27 (A), 
GNPs/GST conjugates incubated for 0 min and 2mins had a low ratio value, which indicates 
that GNPs were completely aggregated. 5mins and 10mins incubation had higher values, 
indicating partial protein coverage, and therefore less aggregation. GNPs/GST incubated 
longer than 20mins showed peaks at 530nm and flat adsorption between 600nm-700nm, 
indicating that GNPs/GST conjugates were stable in the presence of 0.2mM β-ME but only 
after more than 20 minutes incubation.  
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We observed Ab530nm/600nm ≈1 for aggregated GNPs, whereas stable GNPs have Ab530nm/600nm 
≥2. In Figure 3.27 (B), Ab530nm/600nm was plotted versus time of GST adsorption and the graph 
shows that GST needs 20min at least to bind covalently on GNPs surface thorough Au-S bonds. 
This experiment was conducted with 1.5µM GST which is a concentration higher than the one 
used in adsorption rate estimation. According to the Kon calculated above the adsorption at 
this concentration should happen within the very few initial minutes but it is clear that the 
covalent binding takes longer, suggesting some rearrangement on the surface might be involved. 
 
 
 
Figure 3. 27 Displacement of GST and NEM-GST by 0.2mM β-Mercaptoethanol (β-ME). (A, C). GNPs were incubated 
with GST or NEM-GST for different time, 0.2m β-ME was added to GNPs protein conjugates at the end of incubation the 
colloids were measured by UV-vis. (B) and (D) show the adsorption ratio of GST and NEM-GST colloids respectively. 
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Figure 3.27 (C), and Figure 3.27 (D) represent the same experiment of Figure 3.27 (A-B) but 
performed using NEM-GST instead, and they shows disappearance of  the SPR peak at any 
time,  with Ab530nm/600nm  ratios around 1. Figure 3.27 (C) and (D) suggest that NEM-GST was 
replaced by β-ME regardless of the incubation time, which indicates physisorption rather than 
chemisorption. The β-Mercaptoethanol assay showed that thiols are implicated in the long-
term stable binding on GNPs surface.   
Combining the conclusions of affinity binding, kinetics and β-Mercaptoethanol measurements, 
our data suggest that GST is adsorbed to GNPs in two steps. First, electrostatic force brings 
GST close to GNPs surface, the charge of GST dominates the binding rate and affinity. KD and 
∆dMAX values obtained at different pH showed that GST has higher binding to GNPs surface 
by less electrostatic repulsion. Also, the Zeta potential measurement are in agreement with the 
pH. The second step happens between thiols and gold. The thiols need a longer time, in the 
order of 20min to approach the GNPs surface (Figure 3.27(A) and (B)). This is because cysteine 
residues of GST might be initially away from the surface, therefore, the interaction between 
cysteine and GNPs could only occur after GST is close to GNPs surface due to electrostatic 
interaction.  
3.3.7 Equilibrium binding of GST-SNAP25 and SNAP25 to GNPs 
 
The binding kinetics of GST and NEM-GST to GNPs shows that the adsorption of GST to 
GNPs does not have higher affinity or quicker binding rate than NEM-GST, however, the ME 
displacement assay shows that cysteines can bind GNPs by Au-S bonds. These can be used as 
a site-oriented strategy for binding GST fusion proteins to GNPs if they do not have cysteine 
residues apart from those on GST.    
In this part of the study we used GST-SNAP25, where all 4 cysteines of SNAP25 were mutated 
into alanines in this case. GST-SNAP25 was adsorb onto GNPs, supposedly by chemisorption 
between cysteines on GST and GNPs, so to form a stable protein corona surrounding GNPs. 
The rationale behind this configuration is that, as SNAP25 doesn’t have any cysteine, at 
equilibrium it is expected to be exposed to the outside of the protein corona and be available to 
bind other SNARE proteins. Opposite to GST-SNAP25, SNAP25 has no cysteines, and was 
used as a control to support the hypothesis of GST-SNAP25 chemisorption. We also compared 
the affinity of GST-SNAP25 and SNAP25 to establish whether fusion to GST can enhance 
how efficiently a protein binds to GNPs.  
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Figure 3. 28 The affinity measurement of GST-SNAP25 and SNAP25 binding onto GNPs. The increase in size (∆d) 
against concentration (0 µM, 0.15µM, 0.30µM, 0.59µM, 0.87µM, 1.15µM, 1.56µM and 1.96µM) was plotted for GST-
SNAP25 (A) and SNAP25 (B). The ∆d data (black dots) were fitted (dash line) to Equation 1.6. 
The affinity associations of GST-SNAP25 and SNAP25 were obtained by plotting size (∆d) 
against GST concentration (Figure 3.28). According to Equation 1.6, the KD of GST-SNAP25 
and SNAP25 were 0.188µM and 0.343µM respectively and the ∆dMAX of GST-SNAP25 and 
SNAP25 were 9.5nm and 7.6nm respectively. The values are consistent with our previous 
observation that GST binds gold very effectively and here increased the affinity to GNPs of 
SNAP25 when fused to GST. The larger ∆dMAX observed for GST-SNAP25 is consistent with 
the larger size of the molecule (GST-SNAP25 molecular weight is about twice bigger than 
SNAP25).   
Also, the pI of GST-SNAP25 is 5.09 which is higher than SNAP25 (4.66), therefore, GST-
SNAP25 has less negative charges at pH7.2 which might also contribute better binding. 
Consequently, the KD of adsorption of GST-SNAP25 (KD =0.188µM) to GNPs was lower than 
SNAP25 (KD =0.343µM).  
GNPs/GST-SNAP25 conjugates (Figure 3.29) showed a clear peak at 530nm, and Ab530nm/600nm 
was 1.8. These results suggest that GST-SNAP25 binds to GNPs surface efficiently by 
chemisorption, so that β-Mercaptoethanol could not replace the Au-S covalent bond. 
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Figure 3. 29 Displacement of GST-SNAP25 and SNAP25 by 0.2mM β-Mercaptoethanol. 
By contrast, GNPs/SNAP25 did not show a SPR peak in Figure 3.29 upon incubation with β-
Mercaptoethanol and the Ab530nm/600nm value was 0.99. This indicates only physisorption 
between SNAP25 and GNPs, resulting in the GNPs aggregation.   
The β-Mercaptoethanol assay offers indication that GST-SNAP25 binding involves cysteines 
and it is most likely site-oriented. Therefore, GST-SNAP25 could be potentially able to form 
a SNARE complex, for example with Nanolock. This observation is the foundation of our work 
on modular assembly of proteins on GNPs reported in section 3.4.1. 
3.3.8 Equilibrium binding of GST-SpyCatcher and SpyCatcher to GNPs 
 
SpyCatcher and SpyTag pair, similarly to SNAP25 and Nanolock, could be a powerful tool for 
gold nanoparticles modular assembly, but opposite to the SNAREs based system, this would 
offer covalent protein-protein binding through inter-molecular isopeptidic bonds. To assess the 
ability of GST-SpyCatcher fusion to efficiently bind to GNPs, we compared the binding 
affinity of GST-SpyCatcher and SpyCatcher to GNPs surface similarly to what we did for GST-
SNAP25 and SNAP25. Also, β-Mercaptoethanol displacement experiment were used to prove 
the binding orientation between GNPs and GST-SpyCatcher.  
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Figure 3. 30 The affinity measurement of GST-SpyCatcher and SpyCatcher. The increase in size (∆d) against 
concentration (0 µM, 0.15µM, 0.30µM, 0.59µM, 0.87µM, 1.15µM, 1.56µM and 1.96µM). ∆d (black dots) was fitted (dash 
line) to Equation 1.6. 
From the data in Figure 3.30, the KD and ∆dMAX of GST-SpyCatcher were 0.317µM and 
10.9nm, whereas KD and ∆dMAX of SpyCatcher were 0.713µM and 7.6nm respectively. 
Similarly to the case of GST-SNAP25/SNAP25, GST fusion improved the affinity of 
SpyCatcher to gold. The pI of GST-SpyCatcher and SpyCatcher are 5.17 and 4.39 respectively. 
The adsorption was undertook at pH7.2. Based on the finding of 3.3.1, GST-SpyCatcher had 
less negative charges than SpyCatcher at pH7.2, probably contributing to provide a higher 
affinity at this pH because of lower electrostatic force to negative charged GNPs surface. 
∆dMAX of GST-SpyCatcher was about 3.3nm bigger than SpyCatcher, most likely because 
GST-SpyCatcher has a bigger molecular weight than SpyCatcher. 
 
Figure 3. 31 Displacement of GST-SpyCatcher and SpyCatcher by 0.2mM β-Mercaptoethanol. 
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In Figure 3.31, GNPs/GST-SpyCatcher shows clear SPR peaks with and without β-ME, and 
the Ab530nm/600nm value was 2.44. Instead, the peak of GNPs/SpyCatcher disappeared after 
adding β-ME, and the Ab530nm/600nm value was 0.91. The β-Mercaptoethanol displacement 
experiments (Figure 3.31) showed GST-SpyCatcher was stable on GNPs in presence of β-ME, 
on the contrary, SpyCatcher was replaced by β-ME and brought out the GNPs from the 
colloidal suspension. This experiment also suggests the possible site-oriented binding nature 
between GNPs and GST-SpyCatcher, as the only cysteines in GST-SpyCatcher are those on 
GST.  The binding between GNPs/GST-SpyCatcher and SpyTag would be more likely to 
happen in this case. This strategy of modular assembly will be discussed in the following 
section 3.4.2.  
3.4 Modular assembly of proteins on gold nanoparticles  
 
The previous findings proved that GST-SNAP25 and GST-SpyCatcher stably bind to GNPs 
surfaces through the cysteines of GST. This section shows evidence of the ability of these GST 
fusion proteins (GST-SNAP25 and GST-SpyCatcher) adsorbed onto GNPs to form complexes 
with their partner proteins, Nanolock and SpyTag respectively.   
3.4.1 Binding of Nanolock to GST-SNAP25 coated GNPs 
 
To determine the saturation concentration of GST-SNAP25 binding to GNPs and confirm the 
DLS measurements of section 3.3.7, 40nm GNPs were titrated at 7 concentration of GST-
SNAP25 (0.15µM, 0.30 µM, 0.59 µM, 0.87 µM, 1.15 µM, 1.56 µM, and 1.96 µM) and their 
migration was observed on an agarose gel (lanes 1-7 of Figure 3.32). The higher the 
concentration of GST-SNAP25, the faster was the migration of GNPs/GST-SNAP25. As we 
already discussed (see section 3.3.7), GST-SNAP25 (pI=5.08) is negatively charged at pH7.2, 
therefore, the higher concentration of adsorbed GST-SNAP25 contributed more negative 
charge to GNPs/GST-SNAP25 conjugates and determined faster migration. The experiment 
also suggested that the saturation concentration of GST-SNAP25 was around 1.56µM (lane 6 
of Figure 3.32) because there was no migration difference between lane 6 and lane7. This is 
consistent with the affinity association curve (Figure 3.28) of GST-SNAP25 that showed the 
∆d measured by DLS stop increasing from 1.56µM. Conclusively, GST-SNAP25 was able to 
completely cover GNPs surface at a concentration of about 1.5µM. The sample with GNPs 
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only was thoroughly precipitated because of high salt concentration of TBE and did not migrate 
(lane 8 of Figure 3.32). 
 
Figure 3. 32 Agarose gel of GNPs/GST-SNAP25. GST-SNAP25 adsorbed onto GNPs forms a monolayer at 
concentrations larger than 1.56µM. Migration in 0.8% agarose of GNPs with adsorbed GST-SNAP25 at 0.15, 0.30, 0.59, 
0.87, 1.15, 1.56, 1.96 µM concentrations (lanes 1-7); lane 8 has GNPs with no GST-SNAP25 that are unstable in 
0.5xTBE and therefore precipitated in the well. 
In order to verify the ability of GST-SNAP25 adsorbed on GNPs to bind its partner protein 
Nanolock, the GNPs/GST-SNAP25 conjugates were incubated with excess Nanolock for 1 
hour. GST in place of GST-SNAP25 was used as a control. After incubation, the mixtures were 
washed by Buffer B for three times to remove the unbound Nanolock and the bound proteins 
were analysed by SDS-PAGE.  
The Au-S were broken in SDS-PAGE loading buffer at 42°C(Li, Jin et al. 2002) for 10 hours, 
so all the proteins bound to GNPs, including those linked through GST, detached from GNPs. 
The mixture of GNPs and proteins was loaded into SDS-PAGE and the individual proteins 
were displayed in the gel.  
GNPs-adsorbed GST (Figure 3.33A, lane1) and GST-SNAP25 (Figure 3.33A, lane2) were 
used as controls that represent the amount of capture proteins on the nanoparticles. Lanes 3 and 
4 show the same particles upon incubation with Nanolock. Nanolock was captured by GST-
SNAP25 GNPs as clearly shown in lane 4 but GST-only GNPs (lane 3) did not bind any 
Nanolock as expected. This results show that Nanolock specifically bind to GST-SNAP25 
coated GNPs, most likely through the formation of a SNARE complex.       
SNARE proteins coated GNPs were also verified by agarose gel electrophoresis similarly to 
figure 3.32. Opposite to SDS-PAGE, the SNARE complexes should be in near-native 
conditions in the agarose gel. We expected the particles would run into the gel resulting in 
different migration depending on different size/charge, possibly offering a way to compare 
1 2 3 4 5 6 7 8 
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GNPs with GST-SNAP25 and Nanolock or GST-SNAP25 only. We found that GNPs/GST-
SNAP25-Nanolock migrated less than GNPs/GST-SNAP25 as shown in lane 5 compared to 
lane 4 (Figure 3.33B). This is probably due to larger mass of the particle. However, the 
difference in migration was minimal and was not conclusive on its own, unless the results are 
considered together with SDS-PAGE evidence and DLS data (see below). No significant 
migration difference was observed between lane 2 and lane 3 (Figure 3.33B) where GST 
conjugated particles were incubated (lane 3) or not (lane 2) with Nanolock. This is consistent 
with what was observed on SDS-PAGE which showed GST was not able to interact with 
Nanolock.  
GNPs-protein conjugates were analysed by DLS to determine whether the formation of the 
SNARE complex could be evidenced by a change of overall size of the particles. In Figure 3.33 
(C), GNPs/GST-SNAP25 were incubated with Nanolock and the size increase compared to 
GNPs/GST-SNAP25 only. The size of GNPs/GST-SNAP25 (50.57nm) was around 8nm bigger 
than GNPs (42.60nm), and was around 2nm smaller than GNPs/GST-SNAP25-Nanolock 
(52.74nm). This 2nm change was likely due to the binding of Nanolock to GST-SNAP25. In 
Figure 3.33 (D), the size of naked GNPs (41.76nm) was about 7.5nm smaller than GNPs/GST 
(49.20nm) and nearly no change was observed in presence Nanolock (49.18nm). Figure 3.33 
(D) suggested that, as expected, Nanolock did not bind to GST. The modest increment in 
hydrodynamic size upon SNARE complex formation is consistent with the fact that the SNARE 
complex is structurally a rod-shaped coiled-coil with all parallel helices. This structure is more 
rigid than the unstructured SNARE domains before assembly, but most likely not much longer 
along the major axis of the coiled-coil, therefore the SNARE complex formation is unlikely to 
result into a substantial increase of size of the particles.  
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Figure 3. 33 SNARE complex assembled on GNPs surfaces. (A). GNPs protein conjugates were heated in SDS-PAGE gel 
loading buffer at 42°C for 10 hours and then analysed by SDS-PAGE. Lane 1 is GNPs/GST, lane 2 is GNPs/GST-
SNAP25, lane 3 is the mixture of GNPs/GST and Nanolock, lane 4 is the mixture of GNPs/GST-SNAP25 and Nanolock, 
PM is the protein marker (BioRad, Precision Plus ProteinTM Dual Color). (B) GNPs protein conjugates were run in 0.8% 
agarose gel, lane 1 is naked GNPs, lane 2 is GNPs/GST, lane 3 is the mixture of GNPs/GST and Nanolock, lane 4 is 
GNPs/GST-SNAP25, lane 5 is the mixture of GNPs/GST-SNAP25 and Nanolock. (C) DLS analysis of the mixture of 
GNPs/GST-SNAP25 and Nanolock. (D) DLS analysis of the mixture of GNPs/GST and Nanolock. MW is molecular 
weight. 
From these results together, we can draw the conclusion that GST-SNAP25/Nanolock  can be 
used to modularly adsorb proteins by simple mixing, for example a fusion of Nanolock to a 
protein of interest, would likely allow this to bind GNPs through the previously adsorbed GST-
SNAP25 molecules.   
3.4.2 Binding of NEM-GST-SpyTag to GST-SpyCatcher coated GNPs 
 
The limitation of SNARE complex in bio-conjugation is that the coiled-coil, although only in 
harsh conditions, could disassemble. This feature might be useful in some circumstance (for 
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example could be exploited for some form of stimuli-responsive nanoparticle-mediated drug 
delivery), but in many other context a permanent conjugation is more desirable. SpyCatcher 
and SpyTag can form a covalent isopeptide bond, therefore providing a permanent link. Their 
reaction is fast, requires only simple mixing, and shows good specificity. Especially, it is robust 
in a range of experimental conditions: it could not be destroyed by low temperature or non-
ionic detergents (Zakeri, Fierer et al. 2012). The isopeptide bond, opposite to SNARE complex, 
is also stable in boiling SDS buffer (see below). Based on these advantages, SpyCatcher and 
SpyTag could potentially allow a range of use in living cells (37°C) for drug delivery, or for 
pull-downs in cell lysate(Zakeri, Fierer et al. 2012).  
In this study, GST-SpyCatcher was adsorbed onto GNPs, and was expected to form the 
isopeptide bond with NEM-GST-SpyTag by simple mixing. We used SpyTag fused to GST as 
the molecular weight shift in case of binding of SpyTag only would be otherwise too small to 
allow detection by DLS and SDS-PAGE. To prevent potential competition between GST-
SpyTag and GST-SpyCatcher in GNPs binding, we used NEM-GST-SpyTag rather than GST-
SpyTag, so to avoid presence of free cysteines linked to SpyTag and subsequent displacement 
of GST-SpyCatcher from the GNPs.  As the isopeptide bond was expected to be formed 
between SpyCatcher and SpyTag, NEM-GST was used as a negative control to react with GST-
SpyCatcher.  
GST-SpyCatcher was incubated with NEM-GST-SpyTag (Figure 3.34 (A), lane 1) or NEM-
GST (Figure 3.34 (A), lane 2) for 1 hour at room temperature in Buffer B to check whether the 
isopeptide bonds could form between GST-SpyCatcher and NEM-GST-SpyTag. Only lane 1 
shown a sharp band between 50kDa and 75kDa. This suggested that GST-SpyCatcher formed 
an isopeptide bonds with NEM-GST-SpyTag but not with NEM-GST (lane 2).  
GNP/GST-SpyCatcher were incubated with NEM-GST-SpyTag (Figure 3.34 (A), lane 3) and 
NEM-GST (Figure 3.34 (A), lane 4) respectively. The GNPs mixture was washed by Buffer B 
for three times to remove the unreacted proteins. As it was described in 3.4.1, the Au-S bonds 
could be broken after a 10 hours incubation in SDS loading buffer at 42°C. Consequently, the 
GST fusion proteins were detached from GNPs. The mixture was loaded in SDS-PAGE. Lane 
3 shown the complex, but there is only a band corresponding to GST-SpyCatcher in lane 4. 
This suggests that NEM-GST-SpyTag could form an isopeptide bond with GST-SpyCatcher 
on the GNPs surface, NEM-GST could not form a complex with GST-SpyCatcher, therefore, 
it was simply removed when washing by centrifugation.  
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The observation was also confirmed by DLS data. In Figure 3.34 (B), the size of GNPs/GST-
SpyCatcher/NEM-GST-SpyTag was ~2nm bigger than GNPs/GST-SpyCatcher only. In 
contrast, the size of GNPs/GST-SpyCatcher had nearly no change (~0.5nm) after adding NEM-
GST without the SpyTag (Figure 3.34C). 
 
 
Figure 3. 34 Isopeptide bonds formed on GNPs surfaces. (A) 12% precast SDS-PAGE gel showing mixture of GST-
SpyCatcher with NEM-GST-SpyTag (lane 1) or NEM-GST (lane 2). Lane 3: GNPs/GST-SpyCatcher mixed with NEM-
GST-SpyTag. Lane 4: GNPs/GST-SpyCatcher and NEM-GST. PM is the protein marker (BioRad, Precision Plus 
ProteinTM Dual Color). (B) DLS analysis of mixtures of GNPs/GST- SpyCatcher and NEM-GST-SpyTag. (C) DLS 
analysis of mixtures of GNPs/GST- SpyCatcher and NEM-GST. MW is molecular weight. 
In this section, we proved that GNPs/GST-SpyCatcher conjugates could bind and form 
isopeptide bonds with NEM-GST-SpyTag and potentially be used as an easy conjugation 
strategy for functionalization of GNPs with recombinant proteins tagged with SpyTag.  
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3.5 Assembly of gold nanoparticles dimers using SNARE-BSA conjugates 
 
BSA was intended as an alternative to GST to efficiently adsorb SNAREs on GNPs. Similarly 
to GST, BSA could form a stable layer surrounding the particle and prevent SNAREs from 
collapsing on the gold surface, which would compromise their ability to form a complex. In 
this experiment, SNAP25C1-Cy3 was used to trigger the SNARE complex formation between 
GNPs/SyntaxinC1-BSA and GNPs/SynaptobrevinC1-BSA. In this case, the complex could be 
also visualized under UV light due to the Cy3 on SNAP25.In section 3.2.6, we reported the 
best conditions to synthesize SNARE-BSA and SNAP25C1-Cy3.  
In order to visualize the SNARE complex, SyntaxinC1-BSA, SynaptobrevinC1-BSA and 
SNAP25C1-Cy3 were mixed for a 1 hour incubation at room temperature and the heated 
(Figure 3.35, lane 1) and non-heated (Figure 3.35, lane 2) mixture were loaded on SDS-PAGE. 
The gel was observed under UV light first and then stained by InstantBlue. In Figure 3.35, the 
bands above 150kDa (lane 1) corresponds to a molecular weight compatible with the complex 
formed of SyntaxinC1-BSA (75.4kDa), SynaptobrevinC1-BSA (73.8kDa) and SNAP25C1-
Cy3 (25.3kDa). However, there were considerable amounts of un-complexed SNAREs 
(SNAP25 is especially visible as it is very bright). This phenomenon may because BSA is much 
bigger than SyntaxinC1 and SynaptobrevinC1 resulting in the introduction of steric effects, so 
that the coiled-coil complex could not be completely formed or assemble in a form not stable 
in SDS and disassembled into individual SyntaxinC1-BSA, SynaptobrevinC1-BSA and 
SNAP25C1-Cy3. Nevertheless, SNARE-BSA and SNAP25C1-Cy3 were able to combine 
together to some extent, as evidenced by the high molecular weight band that disappears when 
boiling. 
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Figure 3. 35 The SNARE-BSA complex. (A) The SDS-PAGE gel under UV light. (B). The same SDS-PAGE gel of B was 
stained with Instantblue. 1. non-boiled complex: SNAP25C1-Cy3 assembled with SynaptbrevinC1-BSA and SyntaxinC1-
BSA. 2. boiled complex. PM is the protein marker (BioRad, Precision Plus ProteinTM Dual Color). Precast SDS-PAGE 
gel, 170V, 55 minutes. MW is molecular weight. 
The two SNARE-BSA conjugates were adsorbed on different sizes of GNPs to verify whether 
SNAP25C1-Cy3 would trigger SNAREs to form a SNARE complex and bring the GNPs close. 
SyntaxinC1-BSA and SynaptobrevinC1-BSA were adsorbed onto 40nm GNPs and 20nm 
GNPs respectively and then mixed with SANP25C1-Cy3. The AFM image of Figure 3.36 (A) 
shows that a dimer was assembled with one small GNP (20nm) and one big GNP (40nm) as 
expected. The gray line was the specific profile of interest analyzed by Gwyddion (Figure 3.36 
(B)). The Y axis of Figure 3.36 (B) was the step height, with the largest heights representing 
the diameter of GNPs. The distance between the peaks of the two particles (Figure 3.36 (B)) 
was calculated as 57nm, representative of the distance between the centre of the two spheres. 
The schematic (Figure 3.36 (C)) of our hypothetical particle dimer, formed by BSA-SNARE 
conjugates assembled together, shows that the theoretical distance should be 55nm. This is 
calculated from the radius of each gold nanoparticles (20nm and 10nm), two BSA molecules 
(each BSA has a hydrodynamic diameter in the order of 7nm, based on the structure at PDB 
ID 4F5S), and the size of SNARE complex which is about 11nm (calculated from PDB ID 
1SFC). The difference between calculated and measured distance was only 2nm which we 
considered acceptable, especially as the SNARE complex was formed using a new bio-
conjugation method that might give a looser structure than the one obtained for the original X-
ray structure. 
SNARE-BSA complex 
SynaptobrevinC1-BSA and 
SyntaxinC1-BSA 
SNAP25C1-Cy3 
1      2     PM 1       2    PM 
A B 
       250 
       150 
       100 
       75 
       50 
       37 
       25 
       20 
       15 
      10 
MW(kDa) 
97 
 
  
 
Figure 3. 36 Dimers assembled by GNPs and SNARE-BSA conjugates. (A) AFM image of dimer. (B) Particle distance 
analysis from Gwyddion software, Y axis is the height of GNPs, X axis is linear distance (C) The scheme of gold 
nanoparticle dimer assembled by SNARE-BSA and SNAP25C1-Cy3. 
The formation of GNPs dimer suggested that BSA played a role as interface protein which 
adsorb to GNPs surface and oriented SyntaxinC1 and SynaptobrevinC1 so they could form a 
SNARE complex with SNAP25C1-Cy3. The concept of the manufacturing of GNPs dimers by 
SNARE-BSA proteins was proved, however, there were only few dimers in the AFM images 
attempted. In order to obtain a better yield of dimers, it would be beneficial to optimized 
reaction conditions in the future, such as the concentration of SNARE-BSA and SNAP25C1-
Cy3, the incubation time, and the incubation buffers. The poor yield observed might also reflect 
the sub-optimal stability also observed in SDS-PAGE of SNARE-BSA complex in Figure 3.35. 
We haven’t attempted formation of dimers using GST-SNARE fusions, as the GST is at the N-
terminal of the SNARE domain and it would likely interfere with the assembly, which is 
triggered at the very N-terminal. Nevertheless, it might be possible to use a similar approach 
to BSA-SNAREs by fusing GST at the C-terminal.  
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Chapter4. Conclusions and future work 
 
We successfully synthesized two different sizes of gold nanoparticles by sodium citrate method. 
The data of atomic force microscope, nanoparticle tracking analysis, dynamic light scattering 
and ultraviolet-visible spectroscopy show that the GNPs distributions are homogeneous and 
the sizes as expected. We concluded that laboratory-made and commercial particles are equally 
suitable for conjugation experiments and we opted for the latter to guarantee consistency of the 
results. 
Recombinant SNARE proteins with one single cysteine were cloned, synthesized and purified 
for their conjugation to BSA or fluorophores. Their ability to assemble in a coiled coil complex 
was proved, also in the case of BSA-SNAREs bound to GNPs. We believe that self-assembling 
metal nanoparticle dimers of this type could be used to develop a rapid Surface Enhanced 
Raman Scattering (SERS) sensor for single molecule detection. We used two different sizes of 
GNPs linked to either SyntaxinC1-BSA or SynaptobrevinC1-BSA to prove that the dimers 
assemble in the expected hierarchical way. Cy3 bound to SNAP25 is likely to be oriented inside 
the gap between the particles, which is the SERS hot spot. Cy3 could be used as a convenient 
analyte as it has a good Raman signal, but this would require an optimization of the assembly 
conditions, to increase the number of dimers obtained, as currently we estimated an efficiency 
of less than 10%, based on assembled particles versus individual particles in AFM images. In 
a final version of the sensor, a ligand binding molecule would replace Cy3 at the C-terminal of 
SNAP25 and the analyte would bind in the hot spot position when the system assembles. This 
would be the first particle dimers based sensor which works with an analyte in solution. In fact, 
all previous attempts to prove particle dimers based SERS sensors, were not using self-
assembling systems, and the analyte had to be embedded into the dimer during synthesis(Lim, 
Jeon et al. 2010).  
The study of GST adsorption onto GNPs lead to the understanding of the strong interaction 
that this protein has with gold and to indications on how the electrostatic forces and the thiols 
play a significant role in the mechanism of adsorption of proteins to GNPs. For the 
determination of thiols contribution we also developed a novel method based on SPR data 
measured in a simple β-Mercaptoethanol displacement assay. We confirmed previous 
observations(Rahman, Laurent et al. 2013) that adsorption of proteins with cysteines follows a 
two-steps model. In the first step, the electrostatic force brings the protein close to GNPs 
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surface. We estimated for the first time that, at the protein concentrations that are achievable 
on the NPs surface, the second step happens after approximately 20 minutes from initial 
binding of GST.  
It was reported previously (Laera, Ceccone et al. 2011) that proteins are denatured on the GNPs 
surface. GST or BSA used as a sacrificial corona increase the distance between a protein of 
interest and the surface, and this could help preventing denaturation. In fact, we proved that in 
the case of SNARE proteins and SpyCatcher, GST- and BSA-mediated conjugation to GNPs 
preserved their function. Therefore, GST-SNAP25/Nanolock, GST-SpyCatcher/SpyTag and 
also BSA-SNAREs could be used in the synthesis of GNP-based biosensor by fusing a protein 
of interest (antibody or enzyme) to Nanolock, SpyTag or a SNARE. The discovery of GST as 
an ideal protein domain which has excellent affinity to gold, also opens the question whether 
other proteins could be tested or engineered to bind other materials used in biosensors or other 
applications, such as glass, polystyrene or carbon nanotubes. This work contributed to develop 
a number of methods that can be applied in this field of research, whenever a specific material 
would be available in the form of nanoparticles.  
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